201
|
Adamczyk L, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Alekseev I, Alford J, Anson CD, Aparin A, Arkhipkin D, Aschenauer E, Averichev GS, Balewski J, Banerjee A, Barnovska Z, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bhattarai P, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bruna E, Bültmann S, Bunzarov I, Burton TP, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chang Z, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Chwastowski J, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Das S, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derradi de Souza R, Dhamija S, di Ruzza B, Didenko L, Ding F, Dion A, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Eun L, Evdokimov O, Fatemi R, Fazio S, Fedorisin J, Fersch RG, Filip P, Finch E, Fisyak Y, Flores E, Gagliardi CA, Gangadharan DR, Garand D, Geurts F, Gibson A, Gliske S, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huck P, Humanic TJ, Igo G, Jacobs WW, Jena C, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Kikola DP, Kiryluk J, Kisel I, Kisiel A, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kulakov I, Kumar L, Lamont MAC, Landgraf JM, Landry KD, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Luo X, Luszczak A, Ma GL, Ma YG, Madagodagettige Don DMMD, Mahapatra DP, Majka R, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nelson JM, Nogach LV, Novak J, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Poljak N, Porter J, Poskanzer AM, Powell CB, Pruneau C, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Ramachandran S, Raniwala R, Raniwala S, Ray RL, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ross JF, Ruan L, Rusnak J, Sahoo NR, Sahu PK, Sakrejda I, Salur S, Sandacz A, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmidke B, Schmitz N, Schuster TR, Seger J, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma B, Sharma M, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov D, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yi L, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhang JB, Zhang S, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y, Zyzak M. Observation of an energy-dependent difference in elliptic flow between particles and antiparticles in relativistic heavy ion collisions. Phys Rev Lett 2013; 110:142301. [PMID: 25166982 DOI: 10.1103/physrevlett.110.142301] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2013] [Indexed: 06/03/2023]
Abstract
Elliptic flow (v(2)) values for identified particles at midrapidity in Au + Au collisions, measured by the STAR experiment in the beam energy scan at RHIC at sqrt[s(NN)] = 7.7-62.4 GeV, are presented. A beam-energy-dependent difference of the values of v(2) between particles and corresponding antiparticles was observed. The difference increases with decreasing beam energy and is larger for baryons compared to mesons. This implies that, at lower energies, particles and antiparticles are not consistent with the universal number-of-constituent-quark scaling of v(2) that was observed at sqrt[s(NN)] = 200 GeV.
Collapse
Affiliation(s)
- L Adamczyk
- AGH University of Science and Technology, Cracow, Poland
| | - J K Adkins
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - G Agakishiev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - Z Ahammed
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - I Alekseev
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - J Alford
- Kent State University, Kent, Ohio 44242, USA
| | - C D Anson
- The Ohio State University, Columbus, Ohio 43210, USA
| | - A Aparin
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - D Arkhipkin
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - E Aschenauer
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - G S Averichev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - J Balewski
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - A Banerjee
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - Z Barnovska
- Nuclear Physics Institute AS CR, 250 68 Řež/Prague, Czech Republic
| | - D R Beavis
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R Bellwied
- University of Houston, Houston, Texas 77204, USA
| | - M J Betancourt
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - R R Betts
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - A Bhasin
- University of Jammu, Jammu 180001, India
| | - A K Bhati
- Panjab University, Chandigarh 160014, India
| | - P Bhattarai
- University of Texas, Austin, Texas 78712, USA
| | - H Bichsel
- University of Washington, Seattle, Washington 98195, USA
| | - J Bielcik
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - J Bielcikova
- Nuclear Physics Institute AS CR, 250 68 Řež/Prague, Czech Republic
| | - L C Bland
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - I G Bordyuzhin
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow, Russia
| | | | - J Bouchet
- Kent State University, Kent, Ohio 44242, USA
| | - A V Brandin
- Moscow Engineering Physics Institute, Moscow, Russia
| | - S G Brovko
- University of California, Davis, California 95616, USA
| | - E Bruna
- Yale University, New Haven, Connecticut 06520, USA
| | - S Bültmann
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - I Bunzarov
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - T P Burton
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | | | - X Z Cai
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - H Caines
- Yale University, New Haven, Connecticut 06520, USA
| | | | - D Cebra
- University of California, Davis, California 95616, USA
| | - R Cendejas
- Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - M C Cervantes
- Texas A&M University, College Station, Texas 77843, USA
| | - P Chaloupka
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - Z Chang
- Texas A&M University, College Station, Texas 77843, USA
| | | | - H F Chen
- University of Science & Technology of China, Hefei 230026, China
| | - J H Chen
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - J Y Chen
- Central China Normal University (HZNU), Wuhan 430079, China
| | - L Chen
- Central China Normal University (HZNU), Wuhan 430079, China
| | - J Cheng
- Tsinghua University, Beijing 100084, China
| | - M Cherney
- Creighton University, Omaha, Nebraska 68178, USA
| | - A Chikanian
- Yale University, New Haven, Connecticut 06520, USA
| | - W Christie
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - P Chung
- Nuclear Physics Institute AS CR, 250 68 Řež/Prague, Czech Republic
| | | | | | - R Corliss
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - J G Cramer
- University of Washington, Seattle, Washington 98195, USA
| | - H J Crawford
- University of California, Berkeley, California 94720, USA
| | - X Cui
- University of Science & Technology of China, Hefei 230026, China
| | - S Das
- Institute of Physics, Bhubaneswar 751005, India
| | | | - L C De Silva
- University of Houston, Houston, Texas 77204, USA
| | - R R Debbe
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - T G Dedovich
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - J Deng
- Shandong University, Jinan, Shandong 250100, China
| | | | - S Dhamija
- Indiana University, Bloomington, Indiana 47408, USA
| | - B di Ruzza
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - L Didenko
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - F Ding
- University of California, Davis, California 95616, USA
| | - A Dion
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - P Djawotho
- Texas A&M University, College Station, Texas 77843, USA
| | - X Dong
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - J E Draper
- University of California, Davis, California 95616, USA
| | - C M Du
- Institute of Modern Physics, Lanzhou, China
| | | | - J C Dunlop
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - L G Efimov
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - M Elnimr
- Wayne State University, Detroit, Michigan 48201, USA
| | - J Engelage
- University of California, Berkeley, California 94720, USA
| | - G Eppley
- Rice University, Houston, Texas 77251, USA
| | - L Eun
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - O Evdokimov
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - R Fatemi
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - S Fazio
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Fedorisin
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - R G Fersch
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - P Filip
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - E Finch
- Yale University, New Haven, Connecticut 06520, USA
| | - Y Fisyak
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - E Flores
- University of California, Davis, California 95616, USA
| | - C A Gagliardi
- Texas A&M University, College Station, Texas 77843, USA
| | | | - D Garand
- Purdue University, West Lafayette, Indiana 47907, USA
| | - F Geurts
- Rice University, Houston, Texas 77251, USA
| | - A Gibson
- Valparaiso University, Valparaiso, Indiana 46383, USA
| | - S Gliske
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - O G Grebenyuk
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - D Grosnick
- Valparaiso University, Valparaiso, Indiana 46383, USA
| | - A Gupta
- University of Jammu, Jammu 180001, India
| | - S Gupta
- University of Jammu, Jammu 180001, India
| | - W Guryn
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - B Haag
- University of California, Davis, California 95616, USA
| | - O Hajkova
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - A Hamed
- Texas A&M University, College Station, Texas 77843, USA
| | - L-X Han
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - J W Harris
- Yale University, New Haven, Connecticut 06520, USA
| | - J P Hays-Wehle
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - S Heppelmann
- Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - A Hirsch
- Purdue University, West Lafayette, Indiana 47907, USA
| | | | - D J Hofman
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - S Horvat
- Yale University, New Haven, Connecticut 06520, USA
| | - B Huang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - H Z Huang
- University of California, Los Angeles, California 90095, USA
| | - P Huck
- Central China Normal University (HZNU), Wuhan 430079, China
| | - T J Humanic
- The Ohio State University, Columbus, Ohio 43210, USA
| | - G Igo
- University of California, Los Angeles, California 90095, USA
| | - W W Jacobs
- Indiana University, Bloomington, Indiana 47408, USA
| | - C Jena
- National Institute of Science Education and Research, Bhubaneswar 751005, India
| | - E G Judd
- University of California, Berkeley, California 94720, USA
| | | | - K Kang
- Tsinghua University, Beijing 100084, China
| | - J Kapitan
- Nuclear Physics Institute AS CR, 250 68 Řež/Prague, Czech Republic
| | - K Kauder
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - H W Ke
- Central China Normal University (HZNU), Wuhan 430079, China
| | - D Keane
- Kent State University, Kent, Ohio 44242, USA
| | - A Kechechyan
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - A Kesich
- University of California, Davis, California 95616, USA
| | - D P Kikola
- Purdue University, West Lafayette, Indiana 47907, USA
| | - J Kiryluk
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - I Kisel
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Kisiel
- Warsaw University of Technology, Warsaw, Poland
| | - S R Klein
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - D D Koetke
- Valparaiso University, Valparaiso, Indiana 46383, USA
| | | | - J Konzer
- Purdue University, West Lafayette, Indiana 47907, USA
| | - I Koralt
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - W Korsch
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - L Kotchenda
- Moscow Engineering Physics Institute, Moscow, Russia
| | - P Kravtsov
- Moscow Engineering Physics Institute, Moscow, Russia
| | - K Krueger
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - I Kulakov
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Kumar
- Kent State University, Kent, Ohio 44242, USA
| | - M A C Lamont
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J M Landgraf
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - K D Landry
- University of California, Los Angeles, California 90095, USA
| | - S LaPointe
- Wayne State University, Detroit, Michigan 48201, USA
| | - J Lauret
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Lebedev
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R Lednicky
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - J H Lee
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - W Leight
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - M J LeVine
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C Li
- University of Science & Technology of China, Hefei 230026, China
| | - W Li
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - X Li
- Purdue University, West Lafayette, Indiana 47907, USA
| | - X Li
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - Y Li
- Tsinghua University, Beijing 100084, China
| | - Z M Li
- Central China Normal University (HZNU), Wuhan 430079, China
| | - L M Lima
- Universidade de Sao Paulo, Sao Paulo, Brazil
| | - M A Lisa
- The Ohio State University, Columbus, Ohio 43210, USA
| | - F Liu
- Central China Normal University (HZNU), Wuhan 430079, China
| | - T Ljubicic
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - W J Llope
- Rice University, Houston, Texas 77251, USA
| | - R S Longacre
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y Lu
- University of Science & Technology of China, Hefei 230026, China
| | - X Luo
- Central China Normal University (HZNU), Wuhan 430079, China
| | - A Luszczak
- Cracow University of Technology, Cracow, Poland
| | - G L Ma
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - Y G Ma
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | | | | | - R Majka
- Yale University, New Haven, Connecticut 06520, USA
| | - S Margetis
- Kent State University, Kent, Ohio 44242, USA
| | - C Markert
- University of Texas, Austin, Texas 78712, USA
| | - H Masui
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - H S Matis
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - D McDonald
- Rice University, Houston, Texas 77251, USA
| | - T S McShane
- Creighton University, Omaha, Nebraska 68178, USA
| | | | - M K Mitrovski
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y Mohammed
- Texas A&M University, College Station, Texas 77843, USA
| | - B Mohanty
- National Institute of Science Education and Research, Bhubaneswar 751005, India
| | - M M Mondal
- Texas A&M University, College Station, Texas 77843, USA
| | - M G Munhoz
- Universidade de Sao Paulo, Sao Paulo, Brazil
| | - M K Mustafa
- Purdue University, West Lafayette, Indiana 47907, USA
| | - M Naglis
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B K Nandi
- Indian Institute of Technology, Mumbai, India
| | - Md Nasim
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - T K Nayak
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - J M Nelson
- University of Birmingham, Birmingham, United Kingdom
| | - L V Nogach
- Institute of High Energy Physics, Protvino, Russia
| | - J Novak
- Michigan State University, East Lansing, Michigan 48824, USA
| | - G Odyniec
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Ogawa
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - K Oh
- Pusan National University, Pusan, Republic of Korea
| | - A Ohlson
- Yale University, New Haven, Connecticut 06520, USA
| | - V Okorokov
- Moscow Engineering Physics Institute, Moscow, Russia
| | - E W Oldag
- University of Texas, Austin, Texas 78712, USA
| | | | - D Olson
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Pachr
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - B S Page
- Indiana University, Bloomington, Indiana 47408, USA
| | - S K Pal
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - Y X Pan
- University of California, Los Angeles, California 90095, USA
| | - Y Pandit
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - Y Panebratsev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - T Pawlak
- Warsaw University of Technology, Warsaw, Poland
| | - B Pawlik
- Institute of Nuclear Physics PAN, Cracow, Poland
| | - H Pei
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - C Perkins
- University of California, Berkeley, California 94720, USA
| | - W Peryt
- Warsaw University of Technology, Warsaw, Poland
| | - P Pile
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - M Planinic
- University of Zagreb, Zagreb, HR-10002, Croatia
| | - J Pluta
- Warsaw University of Technology, Warsaw, Poland
| | - N Poljak
- University of Zagreb, Zagreb, HR-10002, Croatia
| | - J Porter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A M Poskanzer
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - C B Powell
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - C Pruneau
- Wayne State University, Detroit, Michigan 48201, USA
| | - N K Pruthi
- Panjab University, Chandigarh 160014, India
| | - M Przybycien
- AGH University of Science and Technology, Cracow, Poland
| | | | - J Putschke
- Wayne State University, Detroit, Michigan 48201, USA
| | - H Qiu
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Ramachandran
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - R Raniwala
- University of Rajasthan, Jaipur 302004, India
| | - S Raniwala
- University of Rajasthan, Jaipur 302004, India
| | - R L Ray
- University of Texas, Austin, Texas 78712, USA
| | - C K Riley
- Yale University, New Haven, Connecticut 06520, USA
| | - H G Ritter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | | | - J L Romero
- University of California, Davis, California 95616, USA
| | - J F Ross
- Creighton University, Omaha, Nebraska 68178, USA
| | - L Ruan
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Rusnak
- Nuclear Physics Institute AS CR, 250 68 Řež/Prague, Czech Republic
| | - N R Sahoo
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - P K Sahu
- Institute of Physics, Bhubaneswar 751005, India
| | - I Sakrejda
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Salur
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Sandacz
- Warsaw University of Technology, Warsaw, Poland
| | - J Sandweiss
- Yale University, New Haven, Connecticut 06520, USA
| | - E Sangaline
- University of California, Davis, California 95616, USA
| | - A Sarkar
- Indian Institute of Technology, Mumbai, India
| | - J Schambach
- University of Texas, Austin, Texas 78712, USA
| | | | - A M Schmah
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B Schmidke
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - N Schmitz
- Max-Planck-Institut für Physik, Munich, Germany
| | | | - J Seger
- Creighton University, Omaha, Nebraska 68178, USA
| | - P Seyboth
- Max-Planck-Institut für Physik, Munich, Germany
| | - N Shah
- University of California, Los Angeles, California 90095, USA
| | - E Shahaliev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - M Shao
- University of Science & Technology of China, Hefei 230026, China
| | - B Sharma
- Panjab University, Chandigarh 160014, India
| | - M Sharma
- Wayne State University, Detroit, Michigan 48201, USA
| | - S S Shi
- Central China Normal University (HZNU), Wuhan 430079, China
| | - Q Y Shou
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - E P Sichtermann
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R N Singaraju
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - M J Skoby
- Indiana University, Bloomington, Indiana 47408, USA
| | - D Smirnov
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - N Smirnov
- Yale University, New Haven, Connecticut 06520, USA
| | - D Solanki
- University of Rajasthan, Jaipur 302004, India
| | - P Sorensen
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - U G deSouza
- Universidade de Sao Paulo, Sao Paulo, Brazil
| | - H M Spinka
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - B Srivastava
- Purdue University, West Lafayette, Indiana 47907, USA
| | | | - J R Stevens
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - R Stock
- University of Frankfurt, Frankfurt, Germany
| | - M Strikhanov
- Moscow Engineering Physics Institute, Moscow, Russia
| | | | | | - M C Suarez
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - M Sumbera
- Nuclear Physics Institute AS CR, 250 68 Řež/Prague, Czech Republic
| | - X M Sun
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Y Sun
- University of Science & Technology of China, Hefei 230026, China
| | - Z Sun
- Institute of Modern Physics, Lanzhou, China
| | - B Surrow
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - D N Svirida
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - T J M Symons
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - J Takahashi
- Universidade Estadual de Campinas, Sao Paulo, Brazil
| | - A H Tang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Z Tang
- University of Science & Technology of China, Hefei 230026, China
| | - L H Tarini
- Wayne State University, Detroit, Michigan 48201, USA
| | - T Tarnowsky
- Michigan State University, East Lansing, Michigan 48824, USA
| | - J H Thomas
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J Tian
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - A R Timmins
- University of Houston, Houston, Texas 77204, USA
| | - D Tlusty
- Nuclear Physics Institute AS CR, 250 68 Řež/Prague, Czech Republic
| | - M Tokarev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - S Trentalange
- University of California, Los Angeles, California 90095, USA
| | - R E Tribble
- Texas A&M University, College Station, Texas 77843, USA
| | - P Tribedy
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | | | - O D Tsai
- University of California, Los Angeles, California 90095, USA
| | - J Turnau
- Institute of Nuclear Physics PAN, Cracow, Poland
| | - T Ullrich
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D G Underwood
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - G Van Buren
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - G van Nieuwenhuizen
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | | | - R Varma
- Indian Institute of Technology, Mumbai, India
| | | | - F Videbæk
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y P Viyogi
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - S Vokal
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - S A Voloshin
- Wayne State University, Detroit, Michigan 48201, USA
| | - A Vossen
- Indiana University, Bloomington, Indiana 47408, USA
| | - M Wada
- University of Texas, Austin, Texas 78712, USA
| | - F Wang
- Purdue University, West Lafayette, Indiana 47907, USA
| | - G Wang
- University of California, Los Angeles, California 90095, USA
| | - H Wang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J S Wang
- Institute of Modern Physics, Lanzhou, China
| | - Q Wang
- Purdue University, West Lafayette, Indiana 47907, USA
| | - X L Wang
- University of Science & Technology of China, Hefei 230026, China
| | - Y Wang
- Tsinghua University, Beijing 100084, China
| | - G Webb
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - J C Webb
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - G D Westfall
- Michigan State University, East Lansing, Michigan 48824, USA
| | - C Whitten
- University of California, Los Angeles, California 90095, USA
| | - H Wieman
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S W Wissink
- Indiana University, Bloomington, Indiana 47408, USA
| | - R Witt
- United States Naval Academy, Annapolis, Maryland 21402, USA
| | - Y F Wu
- Central China Normal University (HZNU), Wuhan 430079, China
| | - Z Xiao
- Tsinghua University, Beijing 100084, China
| | - W Xie
- Purdue University, West Lafayette, Indiana 47907, USA
| | - K Xin
- Rice University, Houston, Texas 77251, USA
| | - H Xu
- Institute of Modern Physics, Lanzhou, China
| | - N Xu
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Q H Xu
- Shandong University, Jinan, Shandong 250100, China
| | - W Xu
- University of California, Los Angeles, California 90095, USA
| | - Y Xu
- University of Science & Technology of China, Hefei 230026, China
| | - Z Xu
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - L Xue
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - Y Yang
- Institute of Modern Physics, Lanzhou, China
| | - Y Yang
- Central China Normal University (HZNU), Wuhan 430079, China
| | - P Yepes
- Rice University, Houston, Texas 77251, USA
| | - L Yi
- Purdue University, West Lafayette, Indiana 47907, USA
| | - K Yip
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - I-K Yoo
- Pusan National University, Pusan, Republic of Korea
| | - M Zawisza
- Warsaw University of Technology, Warsaw, Poland
| | | | - J B Zhang
- Central China Normal University (HZNU), Wuhan 430079, China
| | - S Zhang
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - X P Zhang
- Tsinghua University, Beijing 100084, China
| | - Y Zhang
- University of Science & Technology of China, Hefei 230026, China
| | - Z P Zhang
- University of Science & Technology of China, Hefei 230026, China
| | - F Zhao
- University of California, Los Angeles, California 90095, USA
| | - J Zhao
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - C Zhong
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - X Zhu
- Tsinghua University, Beijing 100084, China
| | - Y H Zhu
- Shanghai Institute of Applied Physics, Shanghai 201800, China
| | - Y Zoulkarneeva
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - M Zyzak
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| |
Collapse
|
202
|
Bie L, Ju Y, Jin Z, Donovan L, Birks S, Grunewald L, Zmuda F, Pilkington G, Kaul A, Chen YH, Dahiya S, Emnett R, Gianino S, Gutmann D, Poschl J, Bianchi E, Bockstaller M, Neumann P, Schuller U, Gevorgian A, Morozova E, Kazantsev I, Iukhta T, Safonova S, Punanov Y, Zheludkova O, Afanasyev B, Buss M, Remke M, Gandhi K, Kool M, Northcott P, Pfister S, Taylor M, Castellino R, Thompson J, Margraf L, Donahue D, Head H, Murray J, Burger P, Wortham M, Reitman Z, He Y, Bigner D, Yan H, Lee C, Triscott J, Foster C, Manoranjan B, Pambid MR, Fotovati A, Berns R, Venugopal C, O'Halloran K, Narendran A, Northcott P, Taylor MD, Singh SK, Singhal A, Rassekh R, Maxwell CA, Dunham C, Dunn SE, Pambid MR, Berns R, Hu K, Adomat H, Moniri M, Chin MY, Hessein M, Zisman N, Maurer N, Dunham C, Guns E, Dunn S, Koks C, De Vleeschouwer S, Graf N, Van Gool S, D'Asti E, Huang A, Korshunov A, Pfister S, Rak J, Gump W, Moriarty T, Gump W, Skjei K, Karkare S, Castelo-Branco P, Choufani S, Mack S, Gallagher D, Zhang C, Merino D, Wasserman J, Kool M, Jones DT, Croul S, Kreitzer F, Largaespada D, Conklin B, Taylor M, Weiss W, Garzia L, Morrissy S, Zayne K, Wu X, Dirks P, Hawkins C, Dick J, Stein L, Collier L, Largaespada D, Dupuy A, Taylor M, Rampazzo G, Moraes L, Paniago M, Oliveira I, Hitzler J, Silva N, Cappellano A, Cavalheiro S, Alves MT, Cerutti J, Toledo S, Liu Z, Zhao X, Mao H, Baxter P, Wang JCY, Huang Y, Yu L, Su J, Adekunle A, Perlaky L, Hurwitz M, Hurwitz R, Lau C, Chintagumpala M, Blaney S, Baruchel S, Li XN, Zhang J, Hariono S, Hashizume R, Fan Q, James CD, Weiss WA, Nicolaides T, Madsen PJ, Slaunwhite ES, Dirks PB, Ma JF, Henn RE, Hanno AG, Boucher KL, Storm PB, Resnick AC, Lourdusamy A, Rogers H, Ward J, Rahman R, Malkin D, Gilbertson R, Grundy R, Lourdusamy A, Rogers H, Ward J, Rahman R, Gilbertson R, Grundy R, Karajannis M, Fisher M, Pfister S, Milla S, Cohen K, Legault G, Wisoff J, Harter D, Merkelson A, Bloom M, Dhall G, Jones D, Korshunov A, Taylor MD, Pfister S, Eberhart C, Sievert A, Resnick A, Zagzag D, Allen J, Hankinson T, Gump J, Serrano-Almeida C, Torok M, Weksberg R, Handler M, Liu A, Foreman N, Garancher A, Rocques N, Miquel C, Sainte-Rose C, Delattre O, Bourdeaut F, Eychene A, Tabori U, Pouponnot C, Danielpour M, Levy R, Antonuk CD, Rodriguez J, Aravena JM, Kim GB, Gate D, Bannykh S, Svendsen C, Huang X, Town T, Breunig J, Amakye D, Robinson D, Rose K, Cho YJ, Ligon KL, Sharp T, Ando Y, Geoerger B, He Y, Doz F, Ashley D, Hargrave D, Casanova M, Tawbi H, Heath J, Bouffet E, Brandes AA, Chisholm J, Rodon J, Dubuc AM, Thomas A, Mita A, MacDonald T, Kieran M, Eisenstat D, Song X, Danielpour M, Levy R, Antonuk CD, Rodriguez J, Hashizume R, Aravena JM, Kim GB, Gate D, Bannykh S, Svendsen C, Town T, Breunig J, Morrissy AS, Mayoh C, Lo A, Zhang W, Thiessen N, Tse K, Moore R, Mungall A, Wu X, Van Meter TE, Cho YJ, Collins VP, MacDonald TJ, Li XN, Stehbens S, Fernandez-Lopez A, Malkin D, Marra MA, Taylor MD, Karajannis M, Legault G, Hagiwara M, Vega E, Merkelson A, Wisoff J, Younger S, Golfinos J, Roland JT, Allen J, Antonuk CD, Levy R, Kim GB, Town T, Danielpour M, Breunig J, Pak E, Barshow S, Zhao X, Ponomaryov T, Segal R, Levy R, Antonuk CD, Aravena JM, Kim GB, Svendsen C, Town T, Danielpour M, Zhu S, Breunig J, Chi S, Cohen K, Fisher M, Biegel J, Bowers D, Fangusaro J, Manley P, Janss A, Zimmerman MA, Wu X, Kieran M, Sayour E, Pham C, Sanchez-Perez L, Snyder D, Flores C, Kemeny H, Xie W, Cui X, Bigner D, Taylor MD, Sampson J, Mitchell D, Bandopadhayay P, Nguyen B, Masoud S, Vue N, Gholamin S, Yu F, Schubert S, Bergthold G, Weiss WA, Mitra S, Qi J, Bradner J, Kieran M, Beroukhim R, Cho YJ, Reddick W, Glass J, Ji Q, Paulus E, James CD, Gajjar A, Ogg R, Vanner R, Remke M, Aviv T, Lee L, Zhu X, Clarke I, Taylor M, Dirks P, Shuman MA, Hamilton R, Pollack I, Calligaris D, Liu X, Feldman D, Thompson C, Ide J, Buhrlage S, Gray N, Kieran M, Jan YN, Stiles C, Agar N, Remke M, Cavalli FMG, Northcott PA, Kool M, Pfister SM, Taylor MD, Project MAGIC, Rakopoulos P, Jan LY, Pajovic S, Buczkowicz P, Morrison A, Bouffet E, Bartels U, Becher O, Hawkins C, Truffaux N, Puget S, Philippe C, Gump W, Castel D, Taylor K, Mackay A, Le Dret L, Saulnier P, Calmon R, Boddaert N, Blauwblomme T, Sainte-Rose C, Jones C, Mutchnick I, Grill J, Liu X, Ebling M, Ide J, Wang L, Davis E, Marchionni M, Stuart D, Alberta J, Kieran M, Li KKW, Stiles C, Agar N, Remke M, Cavalli FMG, Northcott PA, Kool M, Pfister SM, Taylor MD, Project MAGIC, Tien AC, Pang JCS, Griveau A, Rowitch D, Ramkissoon L, Horowitz P, Craig J, Ramkissoon S, Rich B, Bergthold G, Tabori U, Taha H, Ng HK, Bowers D, Hawkins C, Packer R, Eberhart C, Goumnerova L, Chan J, Santagata S, Pomeroy S, Ligon A, Kieran M, Jackson S, Beroukhim R, Ligon K, Kuan CT, Chandramohan V, Keir S, Pastan I, Bigner D, Zhou Z, Ho S, Voss H, Patay Z, Souweidane M, Salloum R, DeWire M, Fouladi M, Goldman S, Chow L, Hummel T, Dorris K, Miles L, Sutton M, Howarth R, Stevenson C, Leach J, Griesinger A, Donson A, Hoffman L, Birks D, Amani V, Handler M, Foreman N, Sangar MC, Pai A, Pedro K, Ditzler SH, Girard E, Olson J, Gustafson WC, Meyerowitz J, Nekritz E, Charron E, Matthay K, Hertz N, Onar-Thomas A, Shokat K, Weiss W, Hanaford A, Raabe E, Eberhart C, Griesinger A, Donson A, Hoffman L, Amani V, Birks D, Gajjar A, Handler M, Mulcahy-Levy J, Foreman N, Olow AK, Dasgupta T, Yang X, Mueller S, Hashizume R, Kolkowitz I, Weiss W, Broniscer A, Resnick AC, Sievert AJ, Nicolaides T, Prados MD, Berger MS, Gupta N, James CD, Haas-Kogan DA, Flores C, Pham C, Dietl SM, Snyder D, Sanchez-Perez L, Bigner D, Sampson J, Mitchell D, Prakash V, Batanian J, Guzman M, Geller T, Pham CD, Wolfl M, Pei Y, Flores C, Snyder D, Bigner DD, Sampson JH, Wechsler-Reya RJ, Mitchell DA, Van Ommeren R, Venugopal C, Manoranjan B, Beilhack A, McFarlane N, Hallett R, Hassell J, Dunn S, Singh S, Dasgupta T, Olow A, Yang X, Hashizume R, Mueller S, Riedel S, Nicolaides T, Kolkowitz I, Weiss W, Prados M, Gupta N, James CD, Haas-Kogan D, Zhao H, Li L, Picotte K, Monoranu C, Stewart R, Modzelewska K, Boer E, Picard D, Huang A, Radiloff D, Lee C, Dunn S, Hutt M, Nazarian J, Dietl S, Price A, Lim KJ, Warren K, Chang H, Eberhart CG, Raabe EH, Persson A, Huang M, Chandler-Militello D, Li N, Vince GH, Berger M, James D, Goldman S, Weiss W, Lindquist R, Tate M, Rowitch D, Alvarez-Buylla A, Hoffman L, Donson A, Eyrich M, Birks D, Griesinger A, Amani V, Handler M, Foreman N, Meijer L, Walker D, Grundy R, O'Dowd S, Jaspan T, Schlegel PG, Dineen R, Fotovati A, Radiloff D, Coute N, Triscott J, Chen J, Yip S, Louis D, Toyota B, Hukin J, Weitzel D, Rassekh SR, Singhal A, Dunham C, Dunn S, Ahsan S, Hanaford A, Taylor I, Eberhart C, Raabe E, Sun YG, Ashcraft K, Stiles C, Han L, Zhang K, Chen L, Shi Z, Pu P, Dong L, Kang C, Cordero F, Lewis P, Liu C, Hoeman C, Schroeder K, Allis CD, Becher O, Gururangan S, Grant G, Driscoll T, Archer G, Herndon J, Friedman H, Li W, Kurtzberg J, Bigner D, Sampson J, Mitchell D, Yadavilli S, Kambhampati M, Becher O, MacDonald T, Bellamkonds R, Packer R, Buckley A, Nazarian J, DeWire M, Fouladi M, Stewart C, Wetmore C, Hawkins C, Jacobs C, Yuan Y, Goldman S, Fisher P, Rodriguez R, Rytting M, Bouffet E, Khakoo Y, Hwang E, Foreman N, Gilbert M, Gilbertson R, Gajjar A, Saratsis A, Yadavilli S, Wetzel W, Snyder K, Kambhampati M, Hall J, Raabe E, Warren K, Packer R, Nazarian J, Thompson J, Griesinger A, Foreman N, Spazojevic I, Rush S, Levy JM, Hutt M, Karajannis MA, Shah S, Eberhart CG, Raabe E, Rodriguez FJ, Gump J, Donson A, Tovmasyan A, Birks D, Handler M, Foreman N, Hankinson T, Torchia J, Khuong-Quang DA, Ho KC, Picard D, Letourneau L, Chan T, Peters K, Golbourn B, Morrissy S, Birks D, Faria C, Foreman N, Taylor M, Rutka J, Pfister S, Bouffet E, Hawkins C, Batinic-Haberle I, Majewski J, Kim SK, Jabado N, Huang A, Ladner T, Tomycz L, Watchmaker J, Yang T, Kaufman L, Pearson M, Dewhirst M, Ogg RJ, Scoggins MA, Zou P, Taherbhoy S, Jones MM, Li Y, Glass JO, Merchant TE, Reddick WE, Conklin HM, Gholamin S, Gajjar A, Khan A, Kumar A, Tye GW, Broaddus WC, Van Meter TE, Shih DJH, Northcott PA, Remke M, Korshunov A, Mitra S, Jones DTW, Kool M, Pfister SM, Taylor MD, Mille F, Levesque M, Remke M, Korshunov A, Izzi L, Kool M, Richard C, Northcott PA, Taylor MD, Pfister SM, Charron F, Yu F, Masoud S, Nguyen B, Vue N, Schubert S, Tolliday N, Kong DS, Sengupta S, Weeraratne D, Schreiber S, Cho YJ, Birks D, Jones K, Griesinger A, Amani V, Handler M, Vibhakar R, Achrol A, Foreman N, Brown R, Rangan K, Finlay J, Olch A, Freyer D, Bluml S, Gate D, Danielpour M, Rodriguez J, Shae JJ, Kim GB, Levy R, Bannykh S, Breunig JJ, Town T, Monje-Deisseroth M, Cho YJ, Weissman I, Cheshier S, Buczkowicz P, Rakopoulos P, Bouffet E, Morrison A, Bartels U, Becher O, Hawkins C, Dey A, Kenney A, Van Gool S, Pauwels F, De Vleeschouwer S, Barszczyk M, Buczkowicz P, Castelo-Branco P, Mack S, Nethery-Brokx K, Morrison A, Taylor M, Dirks P, Tabori U, Hawkins C, Chandramohan V, Keir ST, Bao X, Pastan IH, Kuan CT, Bigner DD, Bender S, Jones D, Kool M, Sturm D, Korshunov A, Lichter P, Pfister SM, Chen M, Lu J, Wang J, Keir S, Zhang M, Zhao S, Mook R, Barak L, Lyerly HK, Chen W, Ramachandran C, Nair S, Escalon E, Khatib Z, Quirrin KW, Melnick S, Kievit F, Stephen Z, Wang K, Silber J, Ellenbogen R, Zhang M, Hutzen B, Studebaker A, Bratasz A, Powell K, Raffel C, Guo C, Chang CC, Wortham M, Chen L, Kernagis D, Qin X, Cho YW, Chi JT, Grant G, McLendon R, Yan H, Ge K, Papadopoulos N, Bigner D, He Y, Cristiano B, Venkataraman S, Birks DK, Alimova I, Harris PS, Dubuc A, Taylor MD, Foreman NK, Vibhakar R, Ichimura K, Fukushima S, Totoki Y, Suzuki T, Mukasa A, Saito N, Kumabe T, Tominaga T, Kobayashi K, Nagane M, Iuchi T, Mizoguchi M, Sasaki T, Tamura K, Sugiyama K, Narita Y, Shibui S, Matsutani M, Shibata T, Nishikawa R, Northcott P, Zichner T, Jones D, Kool M, Jager N, Feychting M, Lannering B, Tynes T, Wesenberg F, Hauser P, Ra YS, Zitterbart K, Jabado N, Chan J, Fults D, Mueller S, Grajkowska W, Lichter P, Korbel J, Pfister S, Kool M, Jones DTW, Jaeger N, Northcott PA, Pugh T, Hovestadt V, Markant SL, Esparza LA, Bourdeaut F, Remke M, Taylor MD, Cho YJ, Pomeroy SL, Schueller U, Korshunov A, Eils R, Wechsler-Reya RJ, Lichter P, Pfister SM, Keir S, Pegram C, Lipp E, Rasheed A, Chandramohan V, Kuan CT, Kwatra M, Yan H, Bigner D, Chornenkyy Y, Buczkowicz P, Agnihotri S, Becher O, Hawkins C, Rogers H, Mayne C, Kilday JP, Coyle B, Grundy R, Sun T, Warrington N, Luo J, Brooks M, Dahiya S, Sengupta R, Rubin J, Erdreich-Epstein A, Robison N, Ren X, Zhou H, Ji L, Margo A, Jones D, Pfister S, Kool M, Sposto R, Asgharzadeh S, Clifford S, Gustafsson G, Ellison D, Figarella-Branger D, Doz F, Rutkowski S, Lannering B, Pietsch T, Broniscer A, Tatevossian R, Sabin N, Klimo P, Dalton J, Lee R, Gajjar A, Ellison D, Garzia L, Dubuc A, Pitcher G, Northcott P, Mariampillai A, Chan T, Skowron P, Wu X, Yao Y, Hawkins C, Peacock J, Zayne K, Croul S, Rutka J, Kenney A, Huang A, Yang V, Baylin S, Salter M, Taylor M, Ward S, Sengupta R, Rubin J, Garzia L, Morrissy S, Skowron P, Jelveh S, Lindsay P, Largaespada D, Collier L, Dupuy A, Hill R, Taylor M, Lulla RR, Laskowski J, Fangusaro J, DiPatri AJ, Alden T, Vanin EF, Tomita T, Goldman S, Soares MB, Rajagopal MU, Lau LS, Hathout Y, Gordish-Dressman H, Rood B, Datar V, Bochare S, Singh A, Khatau S, Fangusaro J, Goldman S, Lulla R, Rajaram V, Gopalakrishnan V, Morfouace M, Shelat A, Jaccus M, Freeman B, Zindy F, Robinson G, Guy K, Stewart C, Gajjar A, Roussel M, Krebs S, Chow K, Yi Z, Brawley V, Ahmed N, Gottschalk S, Lerner R, Harness J, Yoshida Y, Santos R, Torre JDL, Nicolaides T, Ozawa T, James D, Petritsch C, Vitte J, Chareyre F, Stemmer-Rachamimov A, Giovannini M, Hashizume R, Yu-Jen L, Tom M, Ihara Y, Huang X, Waldman T, Mueller S, Gupta N, James D, Shevtsov M, Yakovleva L, Nikolaev B, Dobrodumov A, Onokhin K, Bychkova N, Mikhrina A, Khachatryan W, Guzhova I, Martynova M, Bystrova O, Ischenko A, Margulis B, Martin A, Nirschl C, Polanczyk M, Cohen K, Pardoll D, Drake C, Lim M, Crowther A, Chang S, Yuan H, Deshmukh M, Gershon T, Meyerowitz JG, Gustafson WC, Nekritz EA, Swartling F, Shokat KM, Ruggero D, Weiss WA, Bergthold G, Rich B, Bandopadhayay P, Chan J, Santaga S, Hoshida Y, Golub T, Tabak B, Ferrer-Luna R, Grill J, Wen PY, Stiles C, Kieran M, Ligon K, Beroukhim R, Lulla RR, Laskowski J, Gireud M, Fangusaro J, Goldman S, Gopalakrishnan V, Merino D, Shlien A, Pienkowska M, Tabori U, Gilbertson R, Malkin D, Mueller S, Hashizume R, Yang X, Kolkowitz I, Olow A, Phillips J, Smirnov I, Tom M, Prados M, Berger M, Gupta N, Haas-Kogan D, Beez T, Sarikaya-Seiwert S, Janssen G, Felsberg J, Steiger HJ, Hanggi D, Marino AM, Baryawno N, Johnsen JI, Ostman A, Wade A, Engler JR, Robinson AE, Phillips JJ, Witt H, Sill M, Mack SC, Wani KM, Lambert S, Tzaridis T, Bender S, Jones DT, Milde T, Northcott PA, Kool M, von Deimling A, Kulozik AE, Witt O, Lichter P, Collins VP, Aldape K, Taylor MD, Korshunov A, Pfister SM, Hatcher R, Das C, Datar V, Taylor P, Singh A, Lee D, Fuller G, Ji L, Fangusaro J, Rajaram V, Goldman S, Eberhart C, Gopalakrishnan V, Griveau A, Lerner R, Ihrie R, Sugiarto S, Ihara Y, Reichholf B, Huillard E, Mcmahon M, James D, Phillips J, Buylla AA, Rowitch D, Petritsch C, Snuderl M, Batista A, Kirkpatrick N, de Almodovar CR, Riedemann L, Knevels E, Schmidt T, Peterson T, Roberge S, Bais C, Yip S, Hasselblatt M, Rossig C, Ferrara N, Klagsbrun M, Duda D, Fukumura D, Xu L, Carmeliet P, Jain R, Nguyen A, Pencreach E, Lasthaus C, Lobstein V, Guerin E, Guenot D, Entz-Werle N, Diaz R, Golbourn B, Faria C, Shih D, MacKenzie D, Picard D, Bryant M, Smith C, Taylor M, Huang A, Rutka J, Gromeier M, Desjardins A, Sampson JH, Threatt SJE, Herndon JE, Friedman A, Friedman HS, Bigner DD, Cavalli FMG, Morrissy AS, Li Y, Chu A, Remke M, Thiessen N, Mungall AJ, Bader GD, Malkin D, Marra MA, Taylor MD, Manoranjan B, Wang X, Hallett R, Venugopal C, Mack S, McFarlane N, Nolte S, Scheinemann K, Gunnarsson T, Hassell J, Taylor M, Lee C, Triscott J, Foster C, Dunham C, Hawkins C, Dunn S, Singh S, McCrea HJ, Bander E, Venn RA, Reiner AS, Iorgulescu JB, Puchi LA, Schaefer PM, Cederquist G, Greenfield JP, Tsoli M, Luk P, Dilda P, Hogg P, Haber M, Ziegler D, Mack S, Agnihotri S, Witt H, Shih D, Wang X, Ramaswamy V, Zayne K, Bertrand K, Massimi L, Grajkowska W, Lach B, Gupta N, Weiss W, Guha A, Zadeh G, Rutka J, Korshunov A, Pfister S, Taylor M, Mack S, Witt H, Jager N, Zuyderduyn S, Nethery-Brokx K, Garzia L, Zayne K, Wang X, Barszczyk M, Wani K, Bouffet E, Weiss W, Hawkins C, Rutka J, Bader G, Aldape K, Dirks P, Pfister S, Korshunov A, Taylor M, Engler J, Robinson A, Wade A, Molinaro A, Phillips J, Ramaswamy V, Remke M, Bouffet E, Faria C, Shih D, Gururangan S, McLendon R, Schuller U, Ligon K, Pomeroy S, Jabado N, Dunn S, Fouladi M, Rutka J, Hawkins C, Tabori U, Packer R, Pfister S, Korshunov A, Taylor M, Faria C, Dubuc A, Golbourn B, Diaz R, Agnihotri S, Sabha N, Luck A, Leadly M, Reynaud D, Wu X, Remke M, Ramaswamy V, Northcott P, Pfister S, Croul S, Kool M, Korshunov A, Smith C, Taylor M, Rutka J, Pietsch T, Doerner E, Muehlen AZ, Velez-Char N, Warmuth-Metz M, Kortmann R, von Hoff K, Friedrich C, Rutkowski S, von Bueren A, Lu YJ, James CD, Hashizume R, Mueller S, Phillips J, Gupta N, Sturm D, Northcott PA, Jones DTW, Korshunov A, Picard D, Lichter P, Huang A, Pfister SM, Kool M, Ward J, Teague C, Shriyan B, Grundy R, Rahman R, Taylor K, Mackay A, Morozova O, Butterfield Y, Truffaux N, Philippe C, Vinci M, de Torres C, Cruz O, Mora J, Hargrave D, Puget S, Yip S, Jones C, Grill J, Smith S, Ward J, Tan C, Grundy R, Rahman R, Bjerke L, Mackay A, Nandhabalan M, Burford A, Jury A, Popov S, Bax D, Carvalho D, Taylor K, Vinci M, Bajrami I, McGonnell I, Lord C, Reis R, Hargrave D, Ashworth A, Workman P, Jones C, Carvalho D, Mackay A, Burford A, Bjerke L, Chen L, Kozarewa I, Lord C, Ashworth A, Hargrave D, Reis R, Jones C, Marigil M, Jauregui PJ, Alonso M, Chan TS, Hawkins C, Picard D, Henkin J, Huang A, Trubicka J, Kucharczyk M, Pelc M, Chrzanowska K, Ciara E, Perek-Polnik M, Grajkowska W, Piekutowska-Abramczuk D, Jurkiewicz D, Luczak S, Borucka-Mankiewicz M, Kowalski P, Krajewska-Walasek M, de Mola RML, Laskowski J, Fangusaro J, Costa FF, Vanin EF, Goldman S, Soares MB, Lulla RR, Mann A, Venugopal C, Vora P, Singh M, van Ommeren R, McFarlane N, Manoranjan B, Qazi M, Scheinemann K, MacDonald P, Delaney K, Whitton A, Dunn S, Singh S, Sievert A, Lang SS, Boucher K, Madsen P, Slaunwhite E, Choudhari N, Kellet M, Storm P, Resnick A, Agnihotri S, Burrell K, Fernandez N, Golbourn B, Clarke I, Barszczyk M, Sabha N, Dirks P, Jones C, Rutka J, Zadeh G, Hawkins C, Murphy B, Obad S, Bihannic L, Ayrault O, Zindy F, Kauppinen S, Roussel M, Golbourn B, Agnihotri S, Cairns R, Mischel P, Aldape K, Hawkins C, Zadeh G, Rutka J, Rush S, Donson A, Kleinschmidt-DeMasters B, Bemis L, Birks D, Chan M, Smith A, Handler M, Foreman N, Gronych J, Jones DTW, Zuckermann M, Hutter S, Korshunov A, Kool M, Ryzhova M, Reifenberger G, Pfister SM, Lichter P, Jones DTW, Hovestadt V, Picelli S, Wang W, Northcott PA, Kool M, Jager N, Reifenberger G, Rutkowski S, Pietsch T, Sultan M, Yaspo ML, Landgraf P, Eils R, Korshunov A, Zapatka M, Pfister SM, Radlwimmer B, Lichter P, Huang Y, Mao H, Wang Y, Kogiso M, Zhao X, Baxter P, Man C, Wang Z, Zhou Y, Li XN, Chung AH, Crabtree D, Schroeder K, Becher OJ, Panosyan E, Wang Y, Lasky J, Liu Z, Zhao X, Wang Y, Mao H, Huang Y, Kogiso M, Baxter P, Adesina A, Su J, Picard D, Huang A, Perlaky L, Chintagumpala M, Lau C, Blaney S, Li XN, Huang M, Persson A, Swartling F, Moriarity B. Abstracts. Neuro Oncol 2013. [DOI: 10.1093/neuonc/not047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
203
|
Wang H, Cui X, Li C, Fang J. Separation of Ethyl Acetate-Dichloromethane-Ethanol by Extractive Distillation: Simulation and Optimization. Chem Eng Technol 2013. [DOI: 10.1002/ceat.201200310] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
204
|
Cui X, Ignee A, De Molo C, Schreiber-Dietrich D, Woenckhaus M, Dietrich C. Littoral Cell Angioma of the Spleen. Z Gastroenterol 2013; 51:209-12. [PMID: 23417366 DOI: 10.1055/s-0032-1325556] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
205
|
Yang J, Zhang Y, Cui X, Yao W, Yu X, Cen P, E. Hodges S, E. Fisher W, C. Brunicardi F, Chen C, Yao Q, Li M. Gene Profile Identifies Zinc Transporters Differentially Expressed in Normal Human Organs and Human Pancreatic Cancer. Curr Mol Med 2013. [DOI: 10.2174/1566524011313030009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
206
|
Cui X, Pelekanos M, Liu PY, Burne THJ, McGrath JJ, Eyles DW. The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience 2013; 236:77-87. [PMID: 23352937 DOI: 10.1016/j.neuroscience.2013.01.035] [Citation(s) in RCA: 121] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2012] [Revised: 01/09/2013] [Accepted: 01/15/2013] [Indexed: 01/12/2023]
Abstract
There is growing evidence that vitamin D is a neuroactive steroid capable of regulating multiple pathways important for both brain development and mature brain function. In particular, there is evidence from rodent models that prenatal vitamin D deficiency alters the development of dopaminergic pathways and this disruption is associated with altered behavior and neurochemistry in the adult brain. Although the presence of the vitamin D receptor (VDR) has been noted in the human substantia nigra, there is a lack of direct evidence showing that VDR is present in dopaminergic cells. Here we confirm that the VDR is present in the nucleus of tyrosine hydroxylase (TH)-positive neurons in both the human and rat substantia nigra, and it emerges early in development in the rat, between embryonic day 12 (E12) and E15. Consistent evidence based on immunohistochemistry, real-time PCR and western blot confirmed a pattern of increasing VDR expression in the rat midbrain until weaning. The nuclear expression of VDR in TH-positive neurons during critical periods of brain development suggests that alterations in early life vitamin D status may influence the orderly development of dopaminergic neurons.
Collapse
Affiliation(s)
- X Cui
- Queensland Brain Institute, The University of Queensland, Qld 4072, Australia
| | | | | | | | | | | |
Collapse
|
207
|
Cui X, Zu FQ, Zhang WJ, Wang ZZ, Li XY. Phase competition of Cu64Zr36and its effect on glass forming ability of the alloy. Cryst Res Technol 2012. [DOI: 10.1002/crat.201200337] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
208
|
Willey C, Anderson J, Duarte C, Zhi D, Cui X, Choradia N, Srinivasasainagendra V, Wang J, Gillespie G. Kinomic Proband Model of Radiation Response From Patient-derived GBM Xenolines. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
209
|
Sun YD, Liang Y, Wu JM, Li YZ, Cui X, Qin L. Dynamic QTL analysis for fruit lycopene content and total soluble solid content in a Solanum lycopersicum x S. pimpinellifolium cross. Genet Mol Res 2012; 11:3696-710. [PMID: 22930431 DOI: 10.4238/2012.august.17.8] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Fruit lycopene content and total soluble solid content are important factors determining fruit quality of tomatoes; however, the dynamic quantitative trait loci (QTL) controlling lycopene and soluble solid content have not been well studied. We mapped the chromosomal regions controlling these traits in different periods in F(2:3) families derived from a cross between the domestic and wild tomato species Solanum lycopersicum and S. pimpinellifolium. Fifteen QTLs for lycopene and soluble solid content and other related traits analyzed at three different fruit ripening stages were detected with a composite interval mapping method. These QTLs explained 7-33% of the individual phenotypic variation. QTLs detected in the color-changing period were different from those detected in the other two periods. On chromosome 1, the soluble solid content QTL was located in the same region during the color-changing and full-ripe periods. On chromosome 4, the same QTL for lycopene content was found during the color-changing and full-ripe periods. The QTL for lycopene content on chromosome 4 co-located with the QTL for soluble solid content during the full-ripe period. Co-location of lycopene content QTL and soluble solid content QTLs may be due to pleiotropic effects of a single gene or a cluster of genes via physiological relationships among traits. On chromosome 9, the same two QTLs for lycopene content at two different fruit ripening periods may reflect genes controlling lycopene content that are always expressed in tomato fruit development.
Collapse
Affiliation(s)
- Y D Sun
- Key Laboratory of Horticulture Plant Germplasm and Genetic Improvement, Ministry of Agriculture, College of Horticulture, Northwest A & F University, Yangling, Shaanxi, China
| | | | | | | | | | | |
Collapse
|
210
|
Cui X, Chopp M, Zacharek A, Dai J, Zhang C, Yan T, Ning R, Roberts C, Shehadah A, Kuzmin-Nichols N, Sanberg CD, Chen J. Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome. Neuroscience 2012; 227:223-31. [PMID: 23041512 DOI: 10.1016/j.neuroscience.2012.09.066] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2012] [Revised: 09/25/2012] [Accepted: 09/26/2012] [Indexed: 12/18/2022]
Abstract
Human umbilical cord blood cells (HUCBCs) have been employed as a restorative treatment for experimental stroke. In this study, we investigated whether transplantation of sub-therapeutic doses of HUCBCs and Simvastatin enhances cerebral vascular remodeling after stroke. Adult male Wistar rats (n=34) were subjected to transient middle cerebral artery occlusion (MCAo) and treated with: phosphate-buffered solution (PBS, gavaged daily for 7 days); Simvastatin (0.5mg/kg, gavaged daily for 7 days); HUCBCs (1×10(6), injected once via tail vein); and combination Simvasatin with HUCBCs, starting at 24h after MCAo. There was no significant difference between Simvastatin- or HUCBC-monotherapy and MCAo-alone group. Combination treatment 24h post-stroke significantly increased the perimeter of von Willebrand factor (vWF)-positive vessels, the diameter and density of alpha smooth muscle actin (αSMA)-positive arteries, and the percentage of 5-bromodeoxyuridine (BrdU)-positive endothelial cells (ECs) in the ischemic boundary zone (IBZ) compared with MCAo-alone or HUCBC-monotherapy 14 days after MCAo (p<0.05, n=8/group); Combination treatment significantly increased the densities of vWF-vessels and αSMA-arteries as well as the densities of BrdU-ECs and BrdU-positive smooth muscle cells (SMCs) in vascular walls in the IBZ compared with Simvastatin-monotherapy. Moreover, the increased BrdU-ECs and BrdU-SMCs were significantly correlated with neurological functional outcome 14 days after MCAo. Combination treatment also significantly increased the expression of Angiopoietin-1 (Ang1), Tie2 and Occludin in the IBZ (p<0.05, n=8/group). The in vitro experiments showed that combination treatment and Ang1 significantly increased capillary-like tube formation and arterial cell migration; anti-Ang1 significantly reduced combination treatment-induced tube-formation and artery cell migration (p<0.05, n=6/group). These findings indicated that a combination of sub-therapeutic doses of Simvastatin and HUCBCs treatment of stroke increases Ang1/Tie2 and Occludin expression in the ischemic brain, amplifies endogenous angiogenesis and arteriogenesis, and enhances vascular remodeling which in concert may contribute to functional outcome after stroke.
Collapse
Affiliation(s)
- X Cui
- Department of Neurology, Henry Ford Health System, Detroit, MI 48202, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
211
|
Bi WX, Kong F, Hu XY, Cui X. Role of glutathione in detoxification of copper and cadmium by yeast cells having different abilities to express cup1 protein. Toxicol Mech Methods 2012; 17:371-8. [PMID: 20020960 DOI: 10.1080/15376510601091392] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
ABSTRACT Although copper is an essential metal and cadmium is an environmental pollutant, both are toxic when present in excess. Metallothionein and glutathione are two of the key components that participate in detoxification of copper and cadmium. In the present study the role of glutathione in resistance to copper and cadmium was investigated with the yeast Saccharomyces cerevisiae. The yeast cells used in this study have different abilities to produce glutathione and Cup1 protein, the yeast metallothionein homolog encoded by CUP1 gene. It was demonstrated that Cup1 protein plays a dominant role in buffering excess copper, and yeast does not depend on glutathione to reduce copper toxicity whether it possesses single or multiple copies of CUP1. In fact, excess copper can cause glutathione oxidation and depletion and damage the glutathione system. On the other hand, it was indicated that Cup1 protein is an important cadmium-detoxifying component, and the glutathione system can positively respond to cadmium. In yeast containing single or multiple copies of CUP1, glutathione is an indispensable line of defense against cadmium. Yeast having glutathione and no Cup1 protein is not able to grow in medium containing excess copper, but can tolerate higher concentrations of cadmium. In addition, it was found that yeast, independent of glutathione, can efficiently remove excess copper, whereas it cannot promptly eliminate accumulated cadmium regardless of having glutathione or not.
Collapse
Affiliation(s)
- W X Bi
- Department of Biochemistry, Wakayama Medical University, Kimiidera, Wakayama, Japan
| | | | | | | |
Collapse
|
212
|
Amorim-Costa C, Peng CK, Cui X, Ayres-de-Campos D, Bernardes J. O052 EVALUATION OF A LOW COST PORTABLE DEVICE FOR TRANSABDOMINAL FETAL ELECTROCARDIOGRAM ACQUISITION. Int J Gynaecol Obstet 2012. [DOI: 10.1016/s0020-7292(12)60482-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
213
|
Pollack IF, Jakacki RI, Butterfield L, Okada H, Chiba Y, Hashimoto N, Kagawa N, Kinoshita M, Kijima N, Hirayama R, Oji Y, Tsuboi A, Oka Y, Sugiyama H, Yoshimine T, Valle RD, Tejada S, Inoges S, Idoate MA, de Cerio ALD, Espinos J, Aristu J, Gallego J, Calvo JP, Bendandi M, Zhu J, Chen C, Ravelo A, Yu E, Dhanda R, Schnadig ID, Zhang L, Fan H, Zhang I, Chen X, Wang H, Da Fonseca A, Badie B, Okada H, Butterfield LH, Hamilton RL, Mintz AH, Engh JA, Drappatz J, Lively MO, Chan MD, Salazar AM, Potter DM, Shaw EG, Lieberman FS, Wei J, Kong LY, Wang F, Xu S, Doucette TA, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB, Yang S, Archer GE, Miao H, Cui X, Xie W, Snyder D, Pretorian AJ, Dechkovskaia A, Reap E, Perez LAS, Norberg P, Schmittling R, Mitchell DA, Sampson JH, Wang F, Wei J, Gjyshi O, Kong LY, Xu S, Lang F, Calin G, Heimberger AB, Xu S, Wei J, Kong LY, Wang F, Calin G, Heimberger AB, Walker DG, Crough T, Beagley L, Smith C, Jones L, Khanna R, Hashimoto N, Tsuboi A, Chiba Y, Kijima N, Oka Y, Oji Y, Kinoshita M, Kagawa N, Yoshimine T, Sugiyama H, Kanemura Y, Sumida M, Yoshioka E, Yamamoto A, Kanematsu D, Matsumoto Y, Fukusumi H, Takada A, Nonaka M, Nakajima S, Mori K, Goto S, Kamigaki T, Maekawa R, Shofuda T, Moriuchi S, Yamasaki M, Yeung JT, Hamilton R, Jakacki R, Okada H, Pollack I, Pellegatta S, Eoli M, Antozzi C, Frigerio S, Bruzzone MG, Cuppini L, Nava S, Anghileri E, Cantini G, Prodi E, Ciusani E, Ferroli P, Saini M, Broggi G, Mantegazza R, Parati EA, Finocchiaro G, Hegde M, Corder A, Chow KK, Mukherjee M, Brawley VS, Heslop HE, Gottschalk S, Yvon E, Ahmed N, Gibo DM, Debinski W, Bonomo J, Rossmeisl J, Robertson J, Dickinson P, Salacz ME, Camarata PJ, Ots M, McIntire J, Lovick D, Mitchell DA, Archer G, Bigner D, Friedman H, Lally-Goss D, Perry B, Herndon J, McGehee S, McLendon R, Coleman RE, Sampson J, Hegde M, Grada Z, Byrd T, Shaffer DR, Ghazi A, Brawley VS, Corder A, Schonfeld K, Dotti G, Heslop H, Gottschalk S, Wels W, Baker ML, Ahmed N, Robbins JM, Dickinson PJ, York D, Sturges BK, Martin B, Higgins RJ, Bringas J, Bankiewicz K, Gruber HE, Jolly DJ, Narayana A, Mathew M, Kannan R, Madden K, Golfinos J, Parker E, Ott P, Pavlick A, Bota DA, Pretto C, Hantos P, Hofman FM, Chen TC, Carrillo JA, Schijns VE, Stathopoulos AA, Prins RM, Everson R, Soto H, Lisiero DN, Young E, Liau LM, Archer GE, Xie W, Norberg P, Dechkovskaia A, Friedman A, Bigner DD, Mitchell DA, Sampson JH, Boczkowski D, Mitchell DA, Gururangan SG, Grant G, Driscoll T, Archer G, King J, Boczkowski D, Xie W, Nair S, Perry B, Fuchs H, Kurtzberg J, Friedman H, Bigner D, Sampson J, Shevtsov MA, Pozdnyakov AV, Kim AV, Samochernych KA, Guzhova IV, Romanova IV, Margulis BA, Khachatryan WA. CLIN-IMMUNOTHERAPY/BIOLOGIC THERAPIES. Neuro Oncol 2012. [DOI: 10.1093/neuonc/nos224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
214
|
Fujita M, Zhang R, Nakata S, Kuzushima K, Wainwright DA, Balyasnikova IV, Auffinger B, Ahmed AU, Han Y, Lesniak MS, Knight A, Arnouk H, Gillespie GY, Britt W, Su Y, Lowdell MW, Lamb LS, Wang J, Leiss L, Choi BD, Kuan CT, Cai M, Bigner DD, Sampson JH, Shibahara I, Saito R, Zhang R, Kanamori M, Sonoda Y, Kumabe T, Kikuchi T, So T, Ishii N, Tominaga T, Zhang L, Wang H, Zhang I, Chen X, Da Fonseca A, Fan H, Badie B, Sayour EJ, McLendon P, Reynolds R, Bigner DD, Sampson JH, McLendon R, Mitchell DA, Sayour EJ, Sanchez-Perez L, Pham C, Snyder D, Xie W, Cui X, Bigner DD, Sampson JH, Mitchell DA, McConnell MJ, Broadley KW, Farrand K, Authier A, Brown JH, Hunn M, Hermans I, Cantini G, Pisati F, Pessina S, Finocchiaro G, Pellegatta S, Yeung JT, Hamilton R, Pollack I, Jakacki R, Okada H, Sanchez-Perez L, Choi B, Snyder D, Cui X, Schmittling RJ, Flores C, Johnson L, Archer GA, Bigner DD, Mitchell DA, Sampson JH, Raychaudhuri B, Rayman P, Huang P, Ireland J, Donnola S, Hamburdzumyan D, Finke J, Vogelbaum MA, Batich K, Snyder D, Xie W, Reap E, Archer G, Sampson J, Mitchell D, Martin AM, Nirschl C, Polanczyk M, Cohen KJ, Pardoll DM, Drake CG, Lim M, Rutledge WC, Kong J, Gao J, Gutman DA, Cooper LA, Chisolm C, Scarpace L, Mikkelsen T, Saltz JH, Moreno CS, Brat DJ, Everson RG, Lisiero DN, Soto H, Liau LM, Prins RM, Zhang L, Gonzalez GC, Chae M, Peterson TE, Parney IF, Chae M, Peterson TE, Johnson AJ, Parney IF. LAB-IMMUNOLOGY RESEARCH. Neuro Oncol 2012. [DOI: 10.1093/neuonc/nos223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
215
|
Adamczyk L, Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Aschenauer E, Averichev GS, Balewski J, Bannerjee A, Barnovska Z, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Chwastowski J, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derradi de Souza R, Dhamija S, Didenko L, Ding F, Dion A, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Eun L, Evdokimov O, Fatemi R, Fazio S, Fedorisin J, Fersch RG, Filip P, Finch E, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Gliske S, Gorbunov YN, Grebenyuk OG, Grosnick D, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huck P, Humanic TJ, Huo L, Igo G, Jacobs WW, Jena C, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Luo X, Luszczak A, Ma GL, Ma YG, Madagodagettige Don DMMD, Mahapatra DP, Majka R, Mall OI, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Morozov B, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nogach LV, Novak J, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Ostrowski P, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Powell CB, Prindle D, Pruneau C, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ross JF, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandacz A, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmidke B, Schmitz N, Schuster TR, Seele J, Seger J, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma B, Sharma M, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov D, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yi Y, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Transverse single-spin asymmetry and cross section forπ0andηmesons at large Feynmanxinp↑+pcollisions ats=200 GeV. Int J Clin Exp Med 2012. [DOI: 10.1103/physrevd.86.051101] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
216
|
Sun C, Peng X, Zhu N, Jiang Y, Kang L, Cui X, Guo X, Shi R. [Quantitative determination of sibricose A5 and sibricose A6 in Polygalae radix]. Zhongguo Zhong Yao Za Zhi 2012; 37:1607-1609. [PMID: 22993991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
OBJECTIVE To establish the method for quantitative determination of sibricose A5 and sibricose A6 in Polygalae Radix by HPLC. METHOD The ultrasonic extracting method was applied in sample pre-treatment. The HPLC procedure was performed on the chromatographic column of Agela Promosil C18 (4.6 mm x 250 mm, 5 microm), the mobile phase was acetonitrile-0.1% phosphoric acid water solution (10:90). The detection wavelength was 330 nm and flow velocity was 1 mL x min(-1). The column temperature was 30 degrees C. RESULT The method has good linearity in the ranges of 0.0087-0.0694 g x L(-1) (r = 0.9993) for sibricose A5, 0.0090-0.0723 g x L(-1) (r=0.9991) for sibricose A6. The average recoveries of sibricose A5 and sibricose A6 were 101.7%, 97.87%, with the RSD of 1.7%, 1.6%, respectively. CONCLUSION The method was simple, quick accurate and reliable. It is appropriate for the quantitative determination of sibricose A5 and sibricose A6 in Polygalae Radix.
Collapse
Affiliation(s)
- Changqing Sun
- School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China.
| | | | | | | | | | | | | | | |
Collapse
|
217
|
Adamczyk L, Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Banerjee A, Barnovska Z, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Chwastowski J, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derradi de Souza R, Dhamija S, Didenko L, Ding F, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Eun L, Evdokimov O, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Gliske S, Gorbunov YN, Grebenyuk OG, Grosnick D, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huck P, Humanic TJ, Huo L, Igo G, Jacobs WW, Jena C, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Luo X, Luszczak A, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Morozov B, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nogach LV, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Powell CB, Prindle D, Pruneau C, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma B, Sharma M, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yi Y, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Directed flow of identified particles in Au+Au collisions at √[SNN]=200 GeV at RHIC. Phys Rev Lett 2012; 108:202301. [PMID: 23003142 DOI: 10.1103/physrevlett.108.202301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/16/2011] [Indexed: 06/01/2023]
Abstract
STAR's measurements of directed flow (v1) around midrapidity for π±, K±, KS0, p, and p[over ¯] in Au+Au collisions at √[sNN]=200 GeV are presented. A negative v1(y) slope is observed for most of produced particles (π±, K±, KS0, and p[over ¯]). In 5%-30% central collisions, a sizable difference is present between the v1(y) slope of protons and antiprotons, with the former being consistent with zero within errors. The v1 excitation function is presented. Comparisons to model calculations (RQMD, UrQMD, AMPT, QGSM with parton recombination, and a hydrodynamics model with a tilted source) are made. For those models which have calculations of v1 for both pions and protons, none of them can describe v1(y) for pions and protons simultaneously. The hydrodynamics model with a tilted source as currently implemented cannot explain the centrality dependence of the difference between the v1(y) slopes of protons and antiprotons.
Collapse
Affiliation(s)
- L Adamczyk
- Krakow University of Technology, Crakow, Poland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
218
|
Zhang W, Cui X, Wang D, Liu Y, Yong L, Li N, Jia X. Products of oxidized L-ascorbic acid damage acellular DNA. J Nutr Health Aging 2012; 16:442-4. [PMID: 22555787 DOI: 10.1007/s12603-012-0014-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE L-ascorbic acid can be pro-oxidant and anti-oxidant in different reaction. This study aims to test the effects about products of oxidized L-Ascorbic Acid on acellular DNA. MEASUREMENT Acellular DNA, nuclear DNA fixed on slides, are used in our experiment. There are four groups and one negative. Negative control is sham-treated with buffer(pH 7.2 and AA/ H2O2/fenton free). Experimental groups are treated separately with 0.06 mM L-ascorbic acid (AA) alone(exposed in air), 0.06 mM L-ascorbic acid (AA) alone(no exposure in air), 1.2 mM hydrogen peroxide (H2O2) alone, and a mixture of final concentration of 0.03 mM L-ascorbic acid and 0. 6 mM hydrogen peroxide (AA+ H2O2). Each experimental group consists of 4 slides and each slide is treated for 4 hours at 4 °C in a dark place. The DNA damage is quantified by alkaline Comet Assay. The comet images are analysed by Comet A1.0 software. Differences among groups are compared with SPSS 11.0. RESULTS DNA singlestrand breakage is found to be treatment-dependent in the following sequence: AA+ H2O2> AA(oxidized) > H2O2, AA(without oxidization) and Control. CONCLUSION Acellular DNA can tolerate the low concentration H2O2, but is sensitive to free radical. The results indicate that AA expose in air and mixture of AA and H2O2 can produce •OH and L-dehydroascorbate (DHA), •OH can damage DNA.
Collapse
Affiliation(s)
- W Zhang
- W. Zhang, Institute of Nutrition and Food Safety, Chinese Center for Disease Control and Prevention, Beijing, China.
| | | | | | | | | | | | | |
Collapse
|
219
|
Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Barnby LS, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Braidot E, Brandin AV, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Sánchez MCDLB, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Leyva AD, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, de Souza RD, Didenko L, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Estienne M, Eun L, Evdokimov O, Fachini P, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs WW, Jena C, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Pei H, Peitzmann T, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma M, Shi SS, Shou QY, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, de Toledo AS, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Identified hadron compositions in p+p and Au+Au collisions at high transverse momenta at √S(NN)=200 GeV. Phys Rev Lett 2012; 108:072302. [PMID: 22401197 DOI: 10.1103/physrevlett.108.072302] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/04/2011] [Indexed: 05/31/2023]
Abstract
We report transverse momentum (p(T)≤15 GeV/c) spectra of π(±), K(±), p, p[over ¯], K(S)(0), and ρ(0) at midrapidity in p+p and Au+Au collisions at √S(NN)=200 GeV. Perturbative QCD calculations are consistent with π(±) spectra in p+p collisions but do not reproduce K and p(p[over ¯]) spectra. The observed decreasing antiparticle-to-particle ratios with increasing p(T) provide experimental evidence for varying quark and gluon jet contributions to high-p(T) hadron yields. The relative hadron abundances in Au+Au at p(T)≳8 GeV/c are measured to be similar to the p+p results, despite the expected Casimir effect for parton energy loss.
Collapse
Affiliation(s)
- G Agakishiev
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
220
|
Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Barnby LS, Beavis DR, Behera NK, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Sánchez MCDLB, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Leyva AD, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, de Souza RD, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du CM, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Estienne M, Eun L, Evdokimov O, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs P, Jacobs WW, Jena C, Jin F, Jones PG, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Knospe AG, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Krueger K, Krus M, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li N, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Liu H, Liu J, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nayak TK, Nelson JM, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Pei H, Peitzmann T, Perkins C, Peryt W, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Potukuchi BVKS, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schaub J, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma M, Shi SS, Shou QY, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, de Toledo AS, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Strangeness enhancement in Cu-Cu and Au-Au collisions at √S(NN)=200 GeV. Phys Rev Lett 2012; 108:072301. [PMID: 22401196 DOI: 10.1103/physrevlett.108.072301] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/15/2011] [Indexed: 05/31/2023]
Abstract
We report new STAR measurements of midrapidity yields for the Λ, Λ[over ¯], K(S)(0), Ξ(-), Ξ[over ¯](+), Ω(-), Ω[over ¯](+) particles in Cu+Cu collisions at √S(NN)==200 GeV, and midrapidity yields for the Λ, Λ[over ¯], K(S)(0) particles in Au+Au at √S(NN)==200 GeV. We show that, at a given number of participating nucleons, the production of strange hadrons is higher in Cu+Cu collisions than in Au+Au collisions at the same center-of-mass energy. We find that aspects of the enhancement factors for all particles can be described by a parametrization based on the fraction of participants that undergo multiple collisions.
Collapse
Affiliation(s)
- G Agakishiev
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
221
|
Sachdev U, McEnaney R, Cui X, Tzeng E. Differing Effects of TLR2 and TLR4 Antagonism in Endothelial Cell Angiogenic Behavior: Implications for Angiogenesis After Hindlimb Ischemia. J Surg Res 2012. [DOI: 10.1016/j.jss.2011.11.878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
222
|
Song F, Zhang F, Yin DZ, Hu YS, Fan MX, Ni HH, Nan XL, Cui X, Zhou CX, Huang CS, Zhao Q, Ma LH, Xu YM, Xia QJ. Diffusion Tensor Imaging for Predicting Hand Motor Outcome in Chronic Stroke Patients. J Int Med Res 2012; 40:126-33. [PMID: 22429352 DOI: 10.1177/147323001204000113] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVE: Previous studies have indicated that diffusion tensor imaging (DTI) values are related to clinical outcome in stroke patients. This prospective study explored whether DTI values were predictive for hand function outcome in chronic stroke patients. METHODS: The DTI parameters (rλ1, rλ23, fractional anisotropy [rFA] and mean diffusivity [rMD]) were investigated in patients with completely paralysed hands (CPH; n = 10) or partially paralysed hands (PPH; n = 10), by two methods of analysis: segment of the corticospinal tract [sCST] analysis; pure region of interest [ROI] analysis. Spearman's correlation coefficient was used to assess the correlation between the DTI parameters and the following clinical measures: Fugl—Meyer Assessment [FMA]; National Institutes of Health Stroke Scale [NIHSS]. RESULTS: Significant differences were found between CPH and PPH for rFA and rλ23 (sCST analysis) and for rMD and rλ23 (ROI analysis). The rλ23 (sCST analysis) correlated with the NIHSS; the rMD (sCST analysis) correlated with the FMA (hand). CONCLUSION: The three parameters, rFA, rλ23 and rMD may have predictive value for evaluating hand function outcome in chronic stroke patients.
Collapse
Affiliation(s)
- F Song
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - F Zhang
- Department of Rehabilitation Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, China
| | - D-Z Yin
- Shanghai Key Laboratory of Magnetic Resonance, East China Normal University, Shanghai, China
| | - Y-S Hu
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
- State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China
| | - M-X Fan
- Shanghai Key Laboratory of Magnetic Resonance, East China Normal University, Shanghai, China
| | - H-H Ni
- Department of Rehabilitation Medicine, Shanghai Tian Shan Chinese Traditional Medicine Hospital, Shanghai, China
| | - X-L Nan
- Department of Rehabilitation Medicine, Yonghe Branch of Shanghai Huashan Hospital, Shanghai, China
| | - X Cui
- Department of Rehabilitation Medicine, Shanghai Tian Shan Chinese Traditional Medicine Hospital, Shanghai, China
| | - C-X Zhou
- Department of Rehabilitation Medicine, Shanghai Tian Shan Chinese Traditional Medicine Hospital, Shanghai, China
| | - C-S Huang
- Department of Rehabilitation Medicine, Shanghai Tian Shan Chinese Traditional Medicine Hospital, Shanghai, China
| | - Q Zhao
- Department of Rehabilitation Medicine, Shanghai Tian Shan Chinese Traditional Medicine Hospital, Shanghai, China
| | - L-H Ma
- Department of Rehabilitation Medicine, Baoshan Branch of Shanghai Huashan Hospital, Shanghai, China
| | - Y-M Xu
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Q-J Xia
- Department of Rehabilitation Medicine, Baoshan Branch of Shanghai Huashan Hospital, Shanghai, China
| |
Collapse
|
223
|
Wang J, Ray PS, Sim MS, Zhou XZ, Lu KP, Lee AV, Lin X, Bagaria SP, Giuliano AE, Cui X. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling. Oncogene 2012; 31:4798-802. [PMID: 22249250 DOI: 10.1038/onc.2011.635] [Citation(s) in RCA: 87] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Human basal-like breast cancer (BLBC) is an enigmatic and aggressive malignancy with a poor prognosis. There is an urgent need to identify therapeutic targets for BLBC, because current treatment modalities are limited and not effective. The forkhead box transcription factor FOXC1 has recently been identified as a critical functional biomarker for BLBC. However, how it orchestrates BLBC cells was not clear. Here we show that FOXC1 activates the transcription factor nuclear factor-κB (NF-κB) in BLBC cells by increasing p65/RelA protein stability. High NF-κB activity has been associated with estrogen receptor-negative breast cancer, particularly BLBC. The effect of FOXC1 on p65/RelA protein stability is mediated by increased expression of Pin1, a peptidyl-prolyl isomerase. FOXC1 requires NF-κB for its regulation of cell proliferation, migration and invasion. Notably, FOXC1 overexpression renders breast cancer cells more susceptible to pharmacological inhibition of NF-κB. These results suggest that BLBC cells may rely on FOXC1-driven NF-κB signaling. Interventions of this pathway may provide modalities for the treatment of BLBC.
Collapse
Affiliation(s)
- J Wang
- Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
224
|
Cui X. Reply to commentary by Dr. J. Zhang and associates on the article “Complete sequence analysis of mitochondrial DNA of aplastic anemia patients”, published in Genet. Mol. Res. 11 (3): 2130-2137. Genet Mol Res 2012. [DOI: 10.4238/2012.december.21.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
225
|
Krejčí E, Pesevski Z, Dealmeida AC, Mrug M, Fresco VM, Argraves WS, Barth JL, Cui X, Sedmera D. Microarray analysis of normal and abnormal chick ventricular myocardial development. Physiol Res 2012; 61:S137-44. [PMID: 22827870 PMCID: PMC4112186 DOI: 10.33549/physiolres.932379] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
The left and right ventricle originate from distinct parts of the cardiac tube, and several genes are known to be differentially expressed in these compartments. The aims of this study were to determine developmental differences in gene expression between the left and right ventricle, and to assess the effect of altered hemodynamic loading. RNA was extracted from isolated left and right normal chick embryonic ventricles at embryonic day 6, 8, and 10, and from day 8 left atrial ligated hearts with hypoplastic left and dilated right ventricles. cRNA was hybridized to Affymetrix Chicken Genome array according to manufacturer protocols. Microarray analysis identified 302 transcripts that were differentially expressed between the left and right ventricle. Comparative analysis detected 91 genes that were different in left ventricles of ligated hearts compared to age-matched ventricles, while 66 were different in the right ones. A large number of the changes could be interpreted as a delay of normal maturation. The approach described in this study could be used as one of the measures to gauge success of surgical procedures for congenital heart disease and help in determining the optimal time frame for intervention to prevent onset of irreversible changes.
Collapse
Affiliation(s)
- E. Krejčí
- Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic
- Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - Z. Pesevski
- Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic
- Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - A. C. Dealmeida
- Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA
| | - M. Mrug
- Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - V. M. Fresco
- Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA
| | - W. S. Argraves
- Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA
| | - J. L. Barth
- Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA
| | - X. Cui
- Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - D. Sedmera
- Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic
- Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA
| |
Collapse
|
226
|
Cui X, Liu F, Wang J, Zhang W, Wang J, Liu K, Cui S, Zhang J, Xu R. Complete sequence analysis of mitochondrial DNA of aplastic anemia patients. Genet Mol Res 2012; 11:2130-7. [DOI: 10.4238/2012.august.6.16] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
227
|
Zhang Y, Sicot G, Cui X, Vogel M, Wuertzer CA, Lezon-Geyda K, Wheeler J, Harki DA, Muzikar KA, Stolper DA, Dervan PB, Perkins AS. Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide. Biochemistry 2011; 50:10431-41. [PMID: 22039883 PMCID: PMC3619939 DOI: 10.1021/bi200962u] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
The zinc finger protein EVI1 is causally associated with acute myeloid leukemogenesis, and inhibition of its function with a small molecule therapeutic may provide effective therapy for EVI1-expressing leukemias. In this paper we describe the development of a pyrrole-imidazole polyamide to specifically block EVI1 binding to DNA. We first identify essential domains for leukemogenesis through structure-function studies on both EVI1 and the t(3;21)(q26;q22)-derived RUNX1-MDS1-EVI1 (RME) protein, which revealed that DNA binding to the cognate motif GACAAGATA via the first of two zinc finger domains (ZF1, encompassing fingers 1-7) is essential transforming activity. To inhibit DNA binding via ZF1, we synthesized a pyrrole-imidazole polyamide 1, designed to bind to a subsite within the GACAAGATA motif and thereby block EVI1 binding. DNase I footprinting and electromobility shift assays revealed a specific and high affinity interaction between polyamide 1 and the GACAAGATA motif. In an in vivo CAT reporter assay using NIH-3T3-derived cell line with a chromosome-embedded tet-inducible EVI1-VP16 as well as an EVI1-responsive reporter, polyamide 1 completely blocked EVI1-responsive reporter activity. Growth of a leukemic cell line bearing overexpressed EVI1 was also inhibited by treatment with polyamide 1, while a control cell line lacking EVI1 was not. Finally, colony formation by RME was attenuated by polyamide 1 in a serial replating assay. These studies provide evidence that a cell permeable small molecule may effectively block the activity of a leukemogenic transcription factor and provide a valuable tool to dissect critical functions of EVI1 in leukemogenesis.
Collapse
Affiliation(s)
- Yi Zhang
- Department of Pathology and Lab Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States
| | - Géraldine Sicot
- Department of Pathology and Lab Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States
| | - Xiaohui Cui
- Department of Pathology and Lab Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States
| | - Marion Vogel
- Department of Pathology and Lab Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States
| | - Charles A. Wuertzer
- Department of Pathology and Lab Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States
| | - Kimberly Lezon-Geyda
- Department of Pathology, Yale School of Medicine, New Haven, Connecticut 06510, United States
| | - John Wheeler
- Department of Pathology, Yale School of Medicine, New Haven, Connecticut 06510, United States
| | - Daniel A. Harki
- Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States
| | - Katy A. Muzikar
- Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States
| | | | - Peter B. Dervan
- Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States
| | - Archibald S. Perkins
- Department of Pathology and Lab Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States
| |
Collapse
|
228
|
Ganmaa D, Cui X, Feskanich D, Hankinson SE, Willett WC. Milk, dairy intake and risk of endometrial cancer: a 26-year follow-up. Int J Cancer 2011; 130:2664-71. [PMID: 21717454 DOI: 10.1002/ijc.26265] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2011] [Accepted: 06/03/2011] [Indexed: 12/18/2022]
Abstract
Estrogens have a central role in the etiology of endometrial cancer. Milk and dairy products are a source of steroid hormones and growth factors that might have physiological effects in humans. We hypothesized that high intakes of milk and dairy products are associated with an increased risk of endometrial cancer, particularly among postmenopausal women not using hormone therapy. This was a prospective cohort study with 68,019 female participants in the Nurses' Health Study aged 34-59 in 1980. Milk and dairy consumption were assessed in 1980, 1984, 1986, 1990, 1994, 1998 and 2002 as servings per day and the follow-up continued through 2006. The multivariate relative risks (RRs) of adenocarcinoma of the endometrium across categories of cumulatively averaged total dairy consumption compared with < 1 svg/day were: 0.94 (95% CI = 0.71-1.25) for 1-1.4 svg/day, 1.14 (0.87-1.49) for 1.5-1.9 svg/day, 1.10 (0.84-1.44) for 2-2.9 svg/day, 1.26 (0.94-1.70) for ≥ 3 svg/day (p for trend = 0.06). The association between total dairy intake and endometrial cancer was significant only among the postmenopausal women (for ≥ 3 svg/day RR = 1.41, 95% CI = 1.01-1.98, p for trend = 0.02) and was evident only among those who were not currently using hormone therapy (RR = 1.58, 95% CI = 1.05-2.36, p for trend = 0.003). Total dairy intake was not significantly associated with risk of preinvasive endometrial cancer. In conclusion, we observed a marginally significant overall association between dairy intake and endometrial cancer and a stronger association among postmenopausal women who were not using estrogen-containing hormones.
Collapse
Affiliation(s)
- Davaasambuu Ganmaa
- Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA.
| | | | | | | | | |
Collapse
|
229
|
Zhang K, Cai Z, Li Y, Shu J, Pan L, Wan F, Li H, Huang X, He C, Liu Y, Cui X, Xu Y, Gao Y, Wu L, Cao S, Li L. Utilization of human amniotic mesenchymal cells as feeder layers to sustain propagation of human embryonic stem cells in the undifferentiated state. Cell Reprogram 2011; 13:281-8. [PMID: 21718108 DOI: 10.1089/cell.2010.0103] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Human embryonic stem (ES) cells are usually maintained in the undifferentiated state by culturing on feeder cells layers of mouse embryonic fibroblasts (MEFs). However, MEFs are not suitable to support human ES cells used for clinical purpose because of risk of zoonosis from animal cells. Therefore, human tissue-based feeder layers need to be developed for human ES cells for clinical purpose. Hereof we report that human amniotic mesenchymal cells (hAMCs) could act as feeder cells for human ES cells, because they are easily obtained and relatively exempt from ethical problem. Like MEFs, hAMCs could act as feeder cells for human ES cells to grow well on. The self-renewal rate of human ES cells cultured on hAMCs feeders was higher than that on MEFs and human amniotic epithelial cells determined by measurement of colonial diameters and growth curve as well as cell cycle analysis. Both immunofluorescence staining and immunoblotting showed that human ES cells cultured on hAMCs expressed stem cell markers such as Oct-3/4, Sox2, and NANOG. Verified by embryoid body formation in vitro and teratoma formation in vivo, we found out that after 20 passages of culture, human ES cells grown on hAMCs feeders could still retain the potency of differentiating into three germ layers. Taken together, our data suggested hAMCs may be safe feeder cells to sustain the propagation of human ES cells in undifferentiated state for future therapeutic use.
Collapse
Affiliation(s)
- Kehua Zhang
- Department of Immunology, Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
230
|
Cui X, Wang Y, Tang Y, Liu Y, Zhao L, Deng J, Xu G, Peng X, Ju S, Liu G, Yang H. Seipin ablation in mice results in severe generalized lipodystrophy. Hum Mol Genet 2011; 20:3022-30. [DOI: 10.1093/hmg/ddr205] [Citation(s) in RCA: 132] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
231
|
Hauser PM, Bille J, Lass-Flörl C, Geltner C, Feldmesser M, Levi M, Patel H, Muggia V, Alexander B, Hughes M, Follett SA, Cui X, Leung F, Morgan G, Moody A, Perlin DS, Denning DW. Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay. J Clin Microbiol 2011; 49:1872-8. [PMID: 21367988 PMCID: PMC3122670 DOI: 10.1128/jcm.02390-10] [Citation(s) in RCA: 78] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2010] [Accepted: 02/17/2011] [Indexed: 11/20/2022] Open
Abstract
Pneumocystis jirovecii pneumonia (PCP) is a common opportunistic infection. Microscopic diagnosis, including diagnosis using the Merifluor-Pneumocystis direct fluorescent antigen (MP-DFA) test, has limitations. Real-time PCR may assist in diagnosis, but no commercially validated real-time PCR assay has been available to date. MycAssay Pneumocystis is a commercial assay that targets the P. jirovecii mitochondrial large subunit (analytical detection limit, ≤ 3.5 copies/μl of sample). A multicenter trial recruited 110 subjects: 54 with transplants (40 with lung transplants), 32 with nonmalignant conditions, 13 with leukemia, and 11 with solid tumors; 9 were HIV positive. A total of 110 respiratory samples (92% of which were bronchoalveolar lavage [BAL] specimens) were analyzed by PCR. Performance was characterized relative to investigator-determined clinical diagnosis of PCP (including local diagnostic tests), and PCR results were compared with MP-DFA test results for 83 subjects. Thirteen of 14 subjects with PCP and 9/96 without PCP (including 5 undergoing BAL surveillance after lung transplantation) had positive PCR results; sensitivity, specificity, and positive and negative predictive values (PPV and NPV, respectively) were 93%, 91%, 59%, and 99%, respectively. Fourteen of 83 subjects for whom PCR and MP-DFA test results were available had PCP; PCR sensitivity, specificity, PPV, and NPV were 93%, 90%, 65%, and 98%, respectively, and MP-DFA test sensitivity, specificity, PPV, and NPV were 93%, 100%, 100%, and 98%. Of the 9 PCR-positive subjects without PCP, 1 later developed PCP. The PCR diagnostic assay compares well with clinical diagnosis using nonmolecular methods. Additional positive results compared with the MP-DFA test may reflect low-level infection or colonization.
Collapse
Affiliation(s)
- Philippe M. Hauser
- Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Jacques Bille
- Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Cornelia Lass-Flörl
- Department für Hygiene, Mikrobiologie und Sozalmedizin, Medizinische Universität Innsbruck, Innsbruck
| | | | | | | | | | - Victoria Muggia
- Department of Medicine, Montefiore Medical Center, Bronx, New York
| | | | - Martin Hughes
- Myconostica Ltd., Sharston, Manchester, United Kingdom
| | | | - Xiaohui Cui
- Myconostica Ltd., Sharston, Manchester, United Kingdom
| | - Flora Leung
- Myconostica Ltd., Sharston, Manchester, United Kingdom
| | | | - Adrian Moody
- Myconostica Ltd., Sharston, Manchester, United Kingdom
| | - David S. Perlin
- Public Health Research Institute, New Jersey Medical School—UMDNJ, Newark, New Jersey
| | - David W. Denning
- Myconostica Ltd., Sharston, Manchester, United Kingdom
- The National Aspergillosis Centre, The University of Manchester
- Manchester Academic Health Science Centre
- University Hospital of South Manchester, Manchester, United Kingdom
| |
Collapse
|
232
|
Cui X, Rosner B, Willett WC, Hankinson SE. Dietary fat, fiber, and carbohydrate intake in relation to risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2011; 20:978-89. [PMID: 21393567 DOI: 10.1158/1055-9965.epi-10-1089] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Macronutrients such as fat and fiber have been hypothesized to play a role in the etiology of endometrial cancer. METHODS To investigate these associations, the authors analyzed data from the Nurses' Health Study. From 1980 to 2006, 669 invasive adenocarcinoma cases were identified over 1.3 million person-years of follow-up. Dietary intake was assessed in 1980 and updated every 2-4 years. Cox proportional hazard models were used to calculate relative risks (RRs), controlling for total energy and other risk factors. RESULTS Overall, the authors found no significant associations between most dietary factors and endometrial cancer risk. Total fat was associated with a borderline significant decreased risk (top vs. bottom quintile RR = 0.78; 95% CI = 0.60-0.99; P(trend) = 0.18). Findings for animal fat were similar. No inverse associations between dietary fibers and cancer risk were observed. Cereal fiber was modestly positively associated with risk (top vs. bottom quintile RR = 1.38, 95% CI = 1.07-1.79; P(trend) = 0.05). The inverse association with animal fat intake and a positive association with carbohydrate intake were observed among premenopausal but not among postmenopausal women. CONCLUSIONS In this large prospective study, no overall association was observed between dietary fat, fiber, and carbohydrates with endometrial cancer risk, although several of the relationships may vary by menopausal status. IMPACT Dietary fat and fiber intake do not seem to play a major role in endometrial cancer etiology overall. However, further evaluation of these associations, particularly in premenopausal women, is needed.
Collapse
Affiliation(s)
- Xiaohui Cui
- Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
| | | | | | | |
Collapse
|
233
|
Abstract
OBJECTIVE Interpretation of the growing body of global literature on health care risk is compromised by a lack of common understanding and language. This series of articles aims to comprehensively compare laws and regulations, institutional management, and administration of incidence reporting systems on medical risk management in the United Kingdom, the United States, Canada, Australia, and Taiwan, so as to provide evidence and recommendations for health care risk management policy in China. METHODS We searched the official websites of the healthcare risk management agencies of the four countries and one district for laws, regulatory documents, research reports, reviews and evaluation forms concerned with healthcare risk management and assessment. Descriptive comparative analysis was performed on relevant documents. RESULTS A total of 146 documents were included in this study, including 2 laws (1.4%), 17 policy documents (11.6%), 41 guidance documents (28.1%), 37 reviews (25.3%), and 49 documents giving general information (33.6%). The United States government implemented one law and one rule of patient safety management, while the United Kingdom and Australia each issued professional guidances on patient safety improvement. The four countries implemented patient safety management policy on four different levels: national, state/province, hospital, and non-governmental organization. CONCLUSION The four countries and one district adopted four levels of patient safety management, and the administration modes can be divided into an "NGO-led mode" represented by the United States and Canada and a "government-led mode" represented by the United Kingdom, Australia, and Taiwan.
Collapse
Affiliation(s)
- Niuyun Sun
- Clinical Safety and Risk Management Center, National Institute of Hospital Administration, Beijing 100083, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
234
|
McEnaney R, Cui X, Tzeng E, Sachdev U. Requirement For HMGB-1 And Autophagic Signaling In Endothelial Angiogenic Behavior. J Surg Res 2011. [DOI: 10.1016/j.jss.2010.11.487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
235
|
Zhang M, Gao F, Cui X, Zhang Y, Sun Y, Gu J, Sun Y. Development and Validation of an Improved Method for the Quantitation of Sertraline in Human Plasma using LC-MS-MS and Its Application to Bioequivalence Studies. J Chromatogr Sci 2011; 49:89-93. [DOI: 10.1093/chrsci/49.2.89] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
236
|
Cui X, Rosner B, Willett WC, Hankinson SE. Antioxidant intake and risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer 2011; 128:1169-78. [PMID: 20473915 DOI: 10.1002/ijc.25425] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
To investigate the associations between antioxidant intake and risk of endometrial cancer, the authors analyzed data from the prospective Nurses' Health Study. From 1980 to 2006, 669 invasive adenocarcinoma cases were identified over 1.3 million person-years of follow-up. Information on dietary intake was collected in 1980 and updated every 2-4 years. Cox proportional hazard models were used to calculate the multivariate relative risks (RR), controlling for total energy and potential risk factors for endometrial cancer. Overall, the authors found no association between intakes of vitamins A, C, E or carotenoids from foods or supplements and cancer risk. The RR and 95% confidence intervals (CI) for the highest vs. lowest quintiles of vitamins A, C, E and total carotenoids were 1.09 (95% CI: 0.85-1.39), 0.98 (95% CI: 0.76-1.25), 1.07 (95% CI: 0.83-1.38) and 1.12 (95% CI: 0.86-1.45), respectively. Similarly, the use of multivitamins or specific vitamins A, C or E supplements was unassociated with risk. In subgroup analyses, several associations seemed to vary by postmenopausal hormone use. Our results suggest that there is no overall association between dietary antioxidant intake or use of antioxidant supplements with risk of endometrial cancer.
Collapse
Affiliation(s)
- Xiaohui Cui
- Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
| | | | | | | |
Collapse
|
237
|
Cheng L, Sun N, Li Y, Zhang Z, Wang L, Zhou J, Liang M, Cui X, Gao G, Yuan Q. International comparative analyses of incidents reporting systems for healthcare risk management. J Evid Based Med 2011; 4:32-47. [PMID: 21342486 DOI: 10.1111/j.1756-5391.2011.01119.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To compare administration of incidence reporting systems for healthcare risk management in the United Kingdom, the United States, Canada, Australia, and Taiwan, and to provide evidence and recommendations for healthcare risk management policy in China. METHODS We searched the official websites of the healthcare risk management agencies of the four countries and one district for laws, regulatory documents, research reports, reviews, and evaluation forms concerned with healthcare risk management and assessment. Descriptive comparative analysis was performed on relevant documents. RESULTS (1) A total of 142 documents were included in this study. The United States had the most relevant documents (68). (2) The type of incidents from reporting systems has expanded from medication errors and hospital-acquired infections to near-misses, and now includes all patient safety incidents. (3) The incidence-reporting systems can be grouped into two models: government-led and legal/regulatory/NGO-collaborative. (4) In two cases, reporting systems were established for specific incident types: One for death or serious injury events (the sentinel events database in Britain, SIRL), and one for healthcare-associated infections (NHSN in America). (5) Compared to the four countries, Taiwan's system put more emphasis on public welfare, confidentiality, and information sharing. The contents of reporting there covered every aspect of risk management to create a more secure environment. CONCLUSION (1) Britain's national reporting and learning system was representative of a government-led model; (2) The United States was the earliest country to have a reporting system, which included a limited range of incident types. Management of incidents became more reliable with increased application of laws, regulations, and guidances; (3) Both the Canadian and the Australian systems drew from the American experience and are still developing; (4) The Taiwanese system was comprehensive and is an instructional case.
Collapse
Affiliation(s)
- Lan Cheng
- Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
238
|
Soliman PT, Cui X, Zhang Q, Hankinson SE, Lu KH. Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study. Am J Obstet Gynecol 2011; 204:167.e1-5. [PMID: 21047616 PMCID: PMC3032826 DOI: 10.1016/j.ajog.2010.08.045] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2010] [Revised: 07/26/2010] [Accepted: 08/24/2010] [Indexed: 02/03/2023]
Abstract
OBJECTIVE Adiponectin, a protein secreted by adipose cells, is inversely associated with endometrial cancer. Our objective was to assess prediagnostic adiponectin levels in relation to risk of endometrial cancer. STUDY DESIGN This was a prospective nested case-control study within the Nurses' Health Study with 146 cases and 377 controls. Adiponectin was measured using enzyme-linked immunosorbent assay. Logistic regression analyses were performed adjusting for known endometrial cancer risk factors. RESULTS Mean age at diagnosis was 64.6 years. Mean interval between blood draw and diagnosis was 7.4 years (range, 2-13). There was no difference in median adiponectin (cases 12.9 vs controls 12.9 μg/mL; P = .97). Adiponectin >15 μg/mL was not associated with endometrial cancer risk (relative risk = 0.86; 95% confidence interval, 0.53-1.39; P = .48), even among postmenopausal women (odds ratio, 0.66; 95% confidence interval, 0.29-1.5). Results did not vary by time from blood draw to diagnosis (P for heterogeneity = .18). CONCLUSION Prediagnostic adiponectin was not predictive of endometrial cancer risk. Further study will better define the relationship between adiponectin and endometrial cancer.
Collapse
Affiliation(s)
- Pamela T. Soliman
- Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, 1155 Herman Pressler CPB 6.3244, Unit 1362, Houston, Texas 77030, USA.,To whom requests for reprints should be addressed, The Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, PO Box 301439 Unit 1362, Houston, TX 77230-1439. Tel: (713) 745-8902, Fax: (713) 792-7586.
| | - Xiaohui Cui
- Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115
| | - Qian Zhang
- Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, 1155 Herman Pressler CPB 6.3244, Unit 1362, Houston, Texas 77030, USA
| | - Susan E. Hankinson
- Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115,Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115
| | - Karen H. Lu
- Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, 1155 Herman Pressler CPB 6.3244, Unit 1362, Houston, Texas 77030, USA
| |
Collapse
|
239
|
Moran CJ, Ray PS, Bagaria SP, Qu Y, Fleisig AJ, Sim M, Turner RR, Cui X. sFRP-1: A functional prognostic marker for gastric cancer? J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.4_suppl.37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
37 Background: Despite being a leading cause of cancer-related death world wide, gastric adenocarcinoma (GA) lacks distinctive biomarkers and targeted therapies. Underexpression of the E-cadherin gene in GA is associated with an aggressive phenotype and a poor prognosis but the mechanisms of this difference are poorly understood. Developing effective therapies for GA requires identification of critical functional markers and deeper understanding of its pathophysiology. Methods: Unsupervised hierarchical clustering analysis of a publicly available 230-sample GA microarray dataset identified a prominent cluster (21.7%) associated with underexpression of E-cadherin and overexpression of a Wnt-family protein: secreted frizzled-related protein 1 (sFRP-1). Archival GA specimens were then assessed for the expression of sFRP-1 by immunohistochemistry. Prognostic significance was assessed using univariate and multivariate analyses. GA cell lines transfected with sFRP-1 were used to determine the role of sFRP-1 in gastric cancer. Results: 85 patients with GA underwent surgery with curative intent; 39 stained positive for sFRP-1 (46%). In this positive group, sFRP-1 staining was focal; was commonly found on the leading edge of the infiltrating tumor mass; and was not restricted to one histopathologic group, grade, or clinical stage. On univariate analysis T stage, nodal involvement, pathologic stage, nuclear grade, E-cadherin status and sFRP-1 status were predictive of overall survival. In a multivariate model, T stage (p < 0.001), nuclear grade (p < 0.001), E-cadherin status (p = 0.031) and sFRP-1 status (p = 0.0097) were predictive of overall survival. Overexpression of sFRP-1 in GA cell lines induced mesenchymal phenotype, enhanced growth and stem cell-like properties. sFRP-1 also attenuated Wnt signaling and E-cadherin expression, but potentiated Notch and Hedgehog signaling known to be involved in GA progression. These findings suggest a Wnt-independent mechanism mediated by sFRP-1. Conclusions: The aggressive biological subtype of gastric cancer may be linked to overexpression of sFRP-1. Our findings identify sFRP-1 as a functional prognostic biomarker for gastric cancer, which may serve as a potential therapeutic target. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- C. J. Moran
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA
| | - P. S. Ray
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA
| | - S. P. Bagaria
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA
| | - Y. Qu
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA
| | - A. J. Fleisig
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA
| | - M. Sim
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA
| | - R. R. Turner
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA
| | - X. Cui
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA
| |
Collapse
|
240
|
Liu Y, Chen N, Cui X, Zheng X, Deng L, Price S, Karantza V, Minden A. The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis. Oncogene 2010; 29:5883-94. [PMID: 20697354 PMCID: PMC2974003 DOI: 10.1038/onc.2010.329] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
The Pak4 serine/threonine kinase is highly expressed in many cancer cell lines and human tumors. While several studies have addressed the role for Pak4 in transformation of fibroblasts, most human cancers are epithelial in origin. Epithelial cancers are associated not only with changes in cell growth, but also with changes in the cellular organization within the three dimensional (3D) architecture of the affected tissues. Here we used immortalized mouse mammary epithelial cells (iMMECs) as a model system to study the role for Pak4 in mammary tumorigenesis. iMMECs are an excellent model system for studying breast cancer they can grow in 3D-epithelial cell culture, where they form acinar structures that recapitulate in vivo mammary morphogenesis. While Pak4 is expressed at low levels in wild type iMMECs, it is overexpressed in response to oncogenes, such as oncogenic Ras and Her2/neu. Here we found that overexpression of Pak4 in iMMECs leads to changes in 3D acinar architecture that are consistent with oncogenic transformation. These include decreased central acinar cell death, abrogation of lumen formation, cell polarity alterations, and deregulation of acinar size and cell number. Furthermore, iMMECs overexpressing Pak4 form tumors when implanted into the fat pads of athymic mice. Our results suggest that overexpression of Pak4 triggers events that are important for the transformation of mammary epithelial cells. This is likely to be due to the ability of Pak4 to inhibit apoptosis and promote cell survival, and thus subsequent uncontrolled proliferation, and to its ability to deregulate cell shape and polarity.
Collapse
Affiliation(s)
- Y Liu
- Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
| | | | | | | | | | | | | | | |
Collapse
|
241
|
Wu H, Kobayashi T, Wan Q, Shi W, Qian H, Cui X, Li W. Effects of surfactant replacement on alveolar overdistension and plasma cytokines in ventilator-induced lung injury. Acta Anaesthesiol Scand 2010; 54:354-61. [PMID: 19764904 DOI: 10.1111/j.1399-6576.2009.02124.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND Overdistension of the lung causes ventilator-induced lung injury (VILI) accompanied by surfactant abnormalities and inflammatory changes. We investigated the effects of surfactant replacement on overdistension of the terminal airspaces and plasma cytokine levels in VILI. METHODS VILI was induced by high-pressure ventilation (HPV) in rats anesthetized with pentobarbital, followed by ventilation for 2 h in the maintenance mode (tidal volume=10 ml/kg, positive end-expiratory pressure = 7.5 cmH(2)O) with or without surfactant replacement. The sizes of the terminal airspaces were determined after fixing the lungs at an airway pressure of 10 cmH(2)O on deflation. Cytokine levels were assessed by enzyme-linked immunosorbent assay. RESULTS The mean ratio of the largest terminal airspace size class (> or = 64,000 microm(2)) was increased from 13.4% to 32.0% by HPV (P<0.05). After maintenance-mode ventilation, the ratio decreased to 16.1% with surfactant replacement (P<0.05), but increased to 44.6% without surfactant replacement (P<0.05). Mean macrophage inflammatory protein-2 (MIP-2) levels in the plasma increased from <0.02 to 6.9 ng/ml with HPV (P<0.05), and further increased to > or = 11.8 ng/ml, regardless of surfactant replacement after maintenance-mode ventilation. Similar tendencies were observed in the interleukin (IL)-6 and IL-10 levels. Tumor necrosis factor-alpha levels were almost negligible during the experiment. CONCLUSION In rats with VILI, surfactant replacement reversed overdistension of the terminal airspaces that may induce barotrauma, but not upregulation of MIP-2, IL-6, and IL-10 within 2 h.
Collapse
Affiliation(s)
- H Wu
- Department of Anesthesiology, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China
| | | | | | | | | | | | | |
Collapse
|
242
|
Wang Y, Yao M, Zhou C, Dong D, Jiang Y, Wei G, Cui X. Erythropoietin promotes spinal cord-derived neural progenitor cell proliferation by regulating cell cycle. Neuroscience 2010; 167:750-7. [PMID: 20167254 DOI: 10.1016/j.neuroscience.2010.02.007] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2009] [Revised: 02/04/2010] [Accepted: 02/04/2010] [Indexed: 02/02/2023]
Abstract
Erythropoietin (EPO) regulates the proliferation and differentiation of erythroid cells by binding to its specific transmembrane receptor (EPOR). The presence of EPO and its receptor in the CNS suggests a different function for EPO other than erythropoiesis. The purpose of the present study was to examine EPOR expression and the role of EPO in the proliferation of neonatal spinal cord-derived neural progenitor cells. The effect of EPO on cell cycle progression was also examined, as well as the signaling cascades involved in this process. Our results showed that EPOR was present in the neural progenitor cells and EPO significantly enhanced their proliferation. Cell cycle analysis of EPO-treated neural progenitor cells indicated a reduced percentage of cells in G0/G1 phase, whereas the cell proliferation index (S phase plus G2/M phase) was increased. EPO also increased the proportion of 5-bromo-2-deoxyuridine (BrdU)-positive cells. With respect to the cell cycle signaling, we examined the cyclin-dependent kinases D1, D2 and E, and cyclin-dependent kinase inhibitors, p21cip1, p27kip1 and p57kip2. No significant differences were observed in the expression of these transcripts after EPO administration. Interestingly, the anti-apoptotic factors, mcl-1 and bcl-2 were significantly increased twofold. Moreover, these specific effects of EPO were eliminated by incubation of the progenitor cells with anti-EPO neutralizing antibody. Those observations suggested that EPO may play a role in normal spinal cord development by regulating cell proliferation and apoptosis.
Collapse
Affiliation(s)
- Y Wang
- Department of Spine Surgery, Second Affiliated Hospital of Harbin Medical University, Hei Long Jiang Province, PR China.
| | | | | | | | | | | | | |
Collapse
|
243
|
Zheng J, Li J, Cui X, Wang X. Abstract No. 21: Comparison of diagnostic sensitivity of C-arm CT, digital subtraction angiography and 64-slice CT in detecting small hepatocellular carcinoma. J Vasc Interv Radiol 2010. [DOI: 10.1016/j.jvir.2009.12.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
244
|
Lan Y, Piao HR, Cui X. Positive inotropic effect of PHR0007 (2-(4-(4-(Benzyloxy)-3-methoxybenzyl)piperazin-1-)-N-(1-methyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamide) on atrial dynamics in beating rabbit atria. Drug Discov Ther 2009; 3:272-277. [PMID: 22495661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
The aim of the present study was to examine the positive inotropic effects and mechanism of action of PHR0007 (2-(4-(4-(Benzyloxy)-3-methoxybenzyl)piperazin-1-)-N-(1-methyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamide) on beating rabbit atria. Atria were obtained from New Zealand white rabbits, and experiments performed using a perfused beating atrial model. The effects of PHR0007 (1, 30, or 100 μmol/L), and of the protein kinase inhibitors, staurosporine (1.0 μmol/L) or H-89 (10 μmol/L), plus PHR0007 (30 μmol/L), on atrial pulse pressure and stroke volume were analyzed. PHR0007 significantly increased atrial pulse pressure and atrial stroke volume in beating rabbit atria compared with control baseline levels. These effects of PHR0007 were completely blocked by pretreatment with either staurosporine (a nonspecific protein kinase inhibitor) or H-89 (a cAMP-dependent protein kinase A inhibitor). In addition, 3-isobutyl-1-methylxanthine (IBMX), a non-specific inhibitor of phosphodiesterases (PDEs), completely blocked the positive inotropic effect of PHR0007 on atrial dynamics, but forskolin, an activator of adenylyl cyclases (AC), failed to modulate PHR0007-induced increases in atrial pulse pressure and stroke volume. In conclusion, these data suggest that PHR0007 produces a positive inotropic effect in rabbit atria via the PDE-cAMP-PKA signaling pathway.
Collapse
Affiliation(s)
- Y Lan
- Department of Physiology, School of Basic Medical Sciences, Ministry of Education, Yanbian University, Yanji, China
| | | | | |
Collapse
|
245
|
Zheng J, Peng B, Xu Y, Xu D, Gao Y, Cui X. UP-2.104: Clinical Study of Laparoscopic Nephron Sparing Surgery for T1 Stage Renal Cell Carcinoma: Report of 32 Cases. Urology 2009. [DOI: 10.1016/j.urology.2009.07.323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
246
|
Xu D, Che J, Cui X, Gao Y, Yao Y, Ren J, Chen M, Chen J, Qu C. POD-10.08: Timely Selection of Necessary Surgical Intervention for Obstructed Patients with Decreased Bladder Compliance and Intact Detrusor Contractility. Urology 2009. [DOI: 10.1016/j.urology.2009.07.1115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
247
|
Che J, Xu D, Cui X, Liu Y, Gao Y, Chen J, Qu C. UP-2.197: Lower Compliance at Second-Half Storage Phase as Main Cause of Hydroureteronephrosis in Patients with Diabetes Insipidus. Urology 2009. [DOI: 10.1016/j.urology.2009.07.416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
248
|
Ray PS, Wang J, Qu Y, Shin-Sim M, Shamonki J, Liu B, Hoon DS, Giuliano AE, Cui X. Role of FOXC1 in regulation of basal-like/triple-negative breast cancer. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.11016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
11016 Background: Class identification studies have proposed 3 prognostically relevant molecular subtypes of breast cancer: luminal, HER2 and basal-like. The latter is associated with poor prognosis but its molecular basis is not clear. We hypothesized a direct correlation between FOXC1 expression and basal-like breast cancer. Methods: Expression of FOXC1, CK5, CK14, EGFR, c-Kit, αB-crystallin, ITGB4 and FOXC2 in basal-like breast cancer was examined using publicly available microarray datasets. A molecular signature of 40 genes sharing co-ordinate up or down regulation with FOXC1 was identified on one microarray (49 patients) and validated on 5 other microarrays (1,232 patients). The clinical significance of FOXC1 gene expression and the FOXC1 gene signature was evaluated using censored survival data. FOXC1 protein expression was assessed by immunohistochemistry (IHC) of a 96-sample breast cancer tissue microarray. Normal breast epithelial, luminal and basal breast cancer cells transfected with FOXC1 vectors were evaluated for cell proliferation, migration and invasion. Results: FOXC1 was found to be consistently and exclusively upregulated in basal-like triple negative breast cancer and was associated with poor overall survival (p<0.0001). The FOXC1 gene signature accurately predicted the basal-like phenotype. IHC analysis of FOXC1 protein expression in human breast cancers confirmed its potential to be used as a clinical biomarker of basal-like breast cancer. Normal breast epithelial cells and luminal breast cancer cells with low or no FOXC1 expression underwent epithelial-to-mesenchymal transition and displayed increased cellular proliferation, migration, invasion, and expression of basal cell markers when FOXC1 was overexpressed. In contrast, knockdown of FOXC1 by shRNA in basal-like breast cancer cells conferred luminal phenotype. Breast cancer progression-linked signaling pathways like NF-κB and p38MAPK were significantly stimulated in basal-like breast cancer as well as by in vitro FOXC1 overexpression. Conclusions: FOXC1 is a dominant determinant of the basal-like phenotype of breast cancer. We propose FOXC1 to be the single best molecular marker of and a potential therapeutic target for basal-like / triple negative breast cancer. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- P. S. Ray
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA; Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - J. Wang
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA; Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Y. Qu
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA; Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - M. Shin-Sim
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA; Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - J. Shamonki
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA; Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - B. Liu
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA; Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - D. S. Hoon
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA; Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - A. E. Giuliano
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA; Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - X. Cui
- John Wayne Cancer Institute, Santa Monica, CA; St. John's Health Center, Santa Monica, CA; Shanghai Jiao Tong University School of Medicine, Shanghai, China
| |
Collapse
|
249
|
Abstract
The polymerase chain reaction makes it possible to analyse DNA sequences in a single cell and has led to a new approach for constructing genetic maps. We describe a procedure called 'sperm typing' which can accurately classify individual meiotic products as recombinant of non-recombinant. This permits the linkage relationships among DNA polymorphisms to be determined without pedigree analysis.
Collapse
Affiliation(s)
- N Arnheim
- Department of Biological Sciences, University of Southern California, Los Angeles 90089-1340
| | | | | |
Collapse
|
250
|
Cui X, Chopp M, Zacharek A, Zhang C, Roberts C, Chen J. Role of endothelial nitric oxide synthetase in arteriogenesis after stroke in mice. Neuroscience 2009; 159:744-50. [PMID: 19154781 DOI: 10.1016/j.neuroscience.2008.12.055] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2008] [Revised: 12/17/2008] [Accepted: 12/23/2008] [Indexed: 02/07/2023]
Abstract
Arteriogenesis supports restored perfusion in the ischemic brain and improves long-term functional outcome after stroke. We investigate the role of endothelial nitric oxide synthetase (eNOS) and a nitric oxide (NO) donor, (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl) amino] diazen-1-ium-1, 2-diolate (DETA-NONOate), in promoting arteriogenesis after stroke. Adult wild-type (WT, n=18) and eNOS-knockout (eNOS(-/-), n=36) mice were subjected to transient (2.5 h) right middle cerebral artery occlusion (MCAo) and were treated with or without DETA-NONOate (0.4 mg/kg) 24 h after MCAo. Functional evaluation was performed. Animals were sacrificed 3 days after MCAo for arterial cell culture studies, or 14 days for immunohistochemical analysis. Consistent with previous studies, eNOS(-/-) mice exhibited a higher mortality rate (P<0.05, n=18/group) and more severe neurological functional deficit after MCAo than WT mice (P<0.05, n=12/group). Decreased arteriogenesis, was evident in eNOS(-/-) mice compared with WT mice, as demonstrated by reduced vascular smooth muscle cell (VSMC) proliferation, arterial density and diameter in the ischemic brain. eNOS(-/-) mice treated with DETA-NONOate had a significantly decreased mortality rate and improved functional recovery, and exhibited enhanced arteriogenesis identified by increased VSMC proliferation, and upregulated arterial density and diameter compared to eNOS(-/-) mice after stroke (P<0.05, n=12/group). To elucidate the mechanisms underlying eNOS/NO mediated arteriogenesis, VSMC migration was measured in vitro. Arterial cell migration significantly decreased in the cultured common carotid artery (CCA) derived from eNOS(-/-) mice 3 days after MCAo compared to WT arterial cells. DETA-NONOate-treatment significantly attenuated eNOS(-/-)-induced decrease of arterial cell migration compared to eNOS(-/-) control artery (P<0.05; n=6/group). Using VSMC culture, DETA-NONOate significantly increased VSMC migration, while inhibition of NOS significantly decreased VSMC migration (P<0.05; n=6/group). Our data indicated that eNOS not only promotes vascular dilation but also increases VSMC proliferation and migration, and thereby enhances arteriogenesis after stroke. Therefore, increase eNOS may play an important role in regulating of arteriogenesis after stroke.
Collapse
Affiliation(s)
- X Cui
- Department of Neurology, Henry Ford Health System, Detroit, MI 48202, USA
| | | | | | | | | | | |
Collapse
|